gmvp_10q.htm

0001477932-21-002300.txt : 20210414 0001477932-21-002300.hdr.sgml : 20210414 20210414161838 ACCESSION NUMBER: 0001477932-21-002300 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210414 DATE AS OF CHANGE: 20210414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GridIron BioNutrients, Inc. CENTRAL INDEX KEY: 0001629205 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364797193 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55852 FILM NUMBER: 21825902 BUSINESS ADDRESS: STREET 1: 6991 EAST CAMELBACK RD. STREET 2: STE D-300 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 BUSINESS PHONE: (800) 570-0438 MAIL ADDRESS: STREET 1: 6991 EAST CAMELBACK RD. STREET 2: STE D-300 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 FORMER COMPANY: FORMER CONFORMED NAME: My Cloudz, Inc. DATE OF NAME CHANGE: 20141224 10-Q 1 gmvp_10q.htm FORM 10-Q gmvp_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to ______

Commission File No. 000-55852

GRIDIRON BIONUTRIENTS, INC.

(Exact name of registrant as specified in its charter)

Nevada		36-4797193
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

6991 East Camelback Rd., Suite D-300

Scottsdale, Arizona 85251

(Address of principal executive offices, zip code)

(800) 570-0438

(Registrant’s telephone number, including area code)

not applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
none		not applicable		not applicable

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☐	Non-accelerated filer	☒
Accelerated filer	☐	Smaller reporting company	☒
Emerging growth company	☐	(Do not check if a smaller reporting company)

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

APPLICABLE ONLY TO CORPORATE ISSUERS

As of April 14, 2021, there were 188,616 shares of common stock outstanding.

GRIDIRON BIONUTRIENTS, INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD ENDED FEBRUARY 28, 2021

INDEX

Index		Page

Part I. Financial Information

Item 1.	Financial Statements	4

	Consolidated Balance Sheets at February 28, 2021 (Unaudited) and August 31, 2020.	4

	Consolidated Statements of Operations for the three and six months ended February 28, 2021 and February 29, 2020 (Unaudited).	5

	Consolidated Statement of Stockholders’ Equity (Deficit) for the three and six months ended February 28, 2021 and February 29, 2020 (Unaudited).	6

	Consolidated Statements of Cash Flow for the six months ended February 28, 2021 and February 29, 2020 (Unaudited).	7

	Notes to Consolidated Financial Statements (Unaudited).	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	18

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	20

Item 4.	Controls and Procedures.	20

Part II. Other Information

Item 1.	Legal Proceedings.	21

Item 1A.	Risk Factors	21

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	21

Item 3.	Defaults Upon Senior Securities.	21

Item 4.	Mine Safety Disclosures.	21

Item 5.	Other Information.	21

Item 6.	Exhibits.	22

Signatures		23

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “aim,” “will,” “would,” “could,” and similar expressions or phrases identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs. Forward-looking statements include, but are not limited to, statements about risks associated with:

•	Risks related to our business, including:
	•	we have a history of losses;
	•	our auditors have raised substantial doubts about our ability to continue as a going concern;
	•	we have a working capital deficit and need to raise additional capital to continue our business model;
	•	our dependence on third party brokers, distributors and co-packers;
	•	the adverse impact of COVID-19 on our company; and
	•	our reliance on our sole officer and director.
•	Risks related to regulation applicable to our industry, including:
	•	significant labeling and warning requirements;
	•	compliance with existing laws and regulations and possible future changes in laws and regulations; and
	•	any failure to protect personal data;
•	Risks related to the ownership of our securities, including:
	•	the applicability of penny stock rules; and
	•	material weaknesses in our internal control over financial reporting; and
	•	the significant dilution to our stockholders upon the conversion of the outstanding Series B Convertible Preferred Stock.

You should read thoroughly this report and the documents that we refer to herein with the understanding that our actual future results may be materially different from and/or worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements including those made in Part I. Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the fiscal year ended August 31, 2020 as filed with the Securities and Exchange Commission (the “SEC”) on December 15, 2020, our Current Report on Form 8-K as filed with the SEC on April 12, 2021, and our other filings with the SEC. New risk factors emerge from time to time and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. These forward-looking statements speak only as of the date of this report, and you should not rely on these statements without also considering the risks and uncertainties associated with these statements and our business.

All references in this report to the “Company”, “Gridiron,” “GridIron BioNutrients”, “we”, “us,” or “our” are to Gridiron BioNutrients, Inc., a Nevada corporation and our wholly-owned subsidiary Gridiron Ventures, Inc., a Nevada corporation.

All share and per share information gives proforma effect to the 308:1 reverse stock split of our common stock effective January 8, 2021.

Table of Contents

GRIDIRON BIONUTRIENTS, INC.
CONSOLIDATED BALANCE SHEETS

	February 28, 2021			August 31, 2020
	(Unaudited)
ASSETS
Current assets:
Cash	$	25,294		$	17,881
Inventory		36,450			37,450
Prepaid expenses		6,000			13,945
Notes receivable, net of discount		61,081			132,852
Total current assets		128,825			202,128

Other assets
Equity investment, net of discount		6,957			2,783
Equipment, net of accumulated depreciation of $3,960 and $3,144, respectively		1,196			2,012
Trademarks		1,680			1,680
Total other assets		9,833			6,475

Total Assets	$	138,658		$	208,603

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
Accounts payable and accrued expenses	$	522,841		$	443,496
Related party payable		61,600			73,469
Derivative liability		881,779			1,454,480
Note payable, current portion		10,000			10,000
Note payable, convertible net of discount		945,769			831,170
Dividends payable		99,145			73,995
Total current liabilities		2,521,134			2,886,610

Commitments and contingencies		-			-

Stockholders' equity (deficiency):
Preferred stock, $0.001 par value; 25,000,000 shares authorized; 8,480,000 and 8,480,000 issued and outstanding as of February 28, 2021 and August 31, 2020, respectively		8,480			8,480
Common stock, $0.001 par value; 200,000,000 shares authorized; 188,616 and 187,194 shares issued and outstanding as of February 28, 2021 and August 31, 2020, Respectively		188			187
Additional paid in capital		1,157,252			1,157,253
Accumulated deficit		(3,548,396	)		(3,843,927	)
Total stockholders' equity (deficiency)		(2,382,476	)		(2,678,007	)

Total Liabilities and Stockholders' equity	$	138,658		$	208,603

The accompanying notes are an integral part of these financial statements.
The common stock issued and outstanding for the financial statements presented have been retroactively
adjusted to reflect the 1-for-308 reverse stock split, which was effective in January 2021.

Table of Contents

GRIDIRON BIONUTRIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

	For the Three Months Ended						For the Six Months Ended
	February 28, 2021			February 29, 2020			February 28, 2021			February 29, 2020

Revenue	$	-		$	-		$	3,080		$	633
Cost of Revenue		-			-			1,421			1,552

Gross margin		-			-			1,659			(919	)

Operating expenses:
Advertising	$	156		$	466		$	365		$	1,837
Consulting fees		15,375			33,375			30,375			58,275
General and administrative		10,675			27,268			22,682			45,089
Professional fees		30,068			(13,057	)		61,689			(2,848	)
Total operating expenses		56,274			48,052			115,111			102,353

Net operating income (loss)		(56,274	)		(48,052	)		(113,452	)		(103,272	)

Other (income) expense:
Interest expense		40,136			40,506			76,886			43,456
Interest income		(21,018	)		-			(48,743	)		-
Impairment expense		-			35,118			-			37,000
Expenses related to convertible notes payable and preferred warrants:
(Gain) loss on change in fair value of derivative liability		(665,343	)		909,090			(572,701	)		1,055,317
Interest accretion		34,088			167,069			114,599			184,031
Debt/Equity issuance costs on convertible notes payable		-			429,800			-			476,408
Other (income) expense		(2,087	)		-			(4,174	)		-
Total Other (income) expense		(614,224	)		1,581,583			(434,133	)		1,796,212

Net income (loss)	$	557,950		$	(1,629,635	)	$	320,681		$	(1,899,484	)

Basic and diluted income (loss) per share	$	2.97		$	(4.18	)	$	1.71		$	(4.58	)

Weighted average number of common
shares outstanding - basic		187,937			390,016			187,563			414,695

The accompanying notes are an integral part of these financial statements.
The common stock issued and outstanding for the financial statements presented have been retroactively
adjusted to reflect the 1-for-308 reverse stock split, which was effective in January 2021.

Table of Contents

GRIDIRON BIONUTRIENTS, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

														Common						Total
											Additional			Stock						Stockholders'
	Preferred Stock				Common Stock						Paid-In			to be			Accumulated			Equity
	Shares		Amount		Shares			Amount			Capital			Issued			Deficit			(Deficit)
Three Months Ended February 29, 2020
Balance at November 30, 2019 (Unaudited)		8,480,000	$	8,480		440,027		$	440		$	1,237,000		$	-		$	(1,495,983	)	$	(250,063	)

Repurchase and retirement of common stock		-		-		(252,833	)		(253	)		(79,747	)		-						(80,000	)
Dividends on preferred stock accrued		-		-		-			-			-			-			(12,575	)		(12,575	)
Net loss, period ended February 29, 2020		-		-		-			-			-			-			(1,629,635	)		(1,629,635	)

Balance at February 29, 2020 (Unaudited)		8,480,000	$	8,480		187,194		$	187		$	1,157,253		$	-		$	(3,138,193	)	$	(1,972,273	)

Six Months Ended February 29, 2020
Balance at August 31, 2019		8,480,000	$	8,480		439,556		$	439		$	1,077,001		$	160,000		$	(1,213,559	)	$	32,361

Issuance of common stock for stock subscription		-		-		742			1			159,999			(160,000	)					-
Repurchase and retirement of common stock		-		-		(253,104	)		(253	)		(79,747	)		-						(80,000	)
Dividends on preferred stock accrued		-		-		-			-			-			-			(25,150	)		(25,150	)
Net loss, period ended February 29, 2020		-		-		-			-			-			-			(1,899,484	)		(1,899,484	)

Balance at February 29, 2020 (Unaudited)		8,480,000	$	8,480		187,194		$	187		$	1,157,253		$	-		$	(3,138,193	)	$	(1,972,273	)

Three Months Ended February 28, 2021
Balance at November 30, 2020		8,480,000	$	8,480		187,194		$	187		$	1,157,253		$	-		$	(4,093,771	)	$	(2,927,851	)

Dividends on preferred stock accrued		-		-		-			-			-			-			(12,575	)		(12,575	)
Adjustment for reverse split		-		-		1,422			1			(1	)		-			-			-
Net loss, period ended February 28, 2021		-		-		-			-			-			-			557,950			557,950

Balance at February 28, 2021 (Unaudited)		8,480,000	$	8,480		188,616		$	188		$	1,157,252		$	-		$	(3,548,396	)	$	(2,382,476	)

Six Months Ended February 28, 2021
Balance at August 31, 2020		8,480,000	$	8,480		187,194		$	187		$	1,157,253		$	-		$	(3,843,927	)	$	(2,678,007	)

Dividends on preferred stock accrued		-		-		-			-			-			-			(25,150	)		(25,150	)
Adjustment for reverse split		-		-		1,422			1			(1	)		-			-			-
Net loss, period ended February 28, 2021		-		-		-			-			-			-			320,681			320,681

Balance at February 28, 2021 (Unaudited)		8,480,000	$	8,480		188,616		$	188		$	1,157,252		$	-		$	(3,548,396	)	$	(2,382,476	)

The accompanying notes are an integral part of these financial statements.
The common stock issued and outstanding for the financial statements presented have been retroactively
adjusted to reflect the 1-for-308 reverse stock split, which was effective in January 2021.

Table of Contents

GRIDIRON BIONUTRIENTS, INC.
Consolidated Statements of Cash Flow (Unaudited)

	For the Six Months Ended
	February 28, 2021			February 29, 2020

Cash flows from operating activities:
Net income (loss)	$	320,681		$	(1,899,484	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		816			1,306
Debt/stock based issue costs		-			476,408
(Gain) Loss on change in fair value of derivative liability		(572,701	)		1,055,317
Interest accretion		114,599			184,031
Amortization of convertible debt discounts		-			20,399
Impairment expense		-			37,000
Prior year correction to note payable, current portion (See Note 5)		-			(39,500	)
Realized income on investment		(4,174	)		-
Changes in operating assets and liabilities:
Inventory		1,000			(320,203	)
Prepaid expenses		7,945			5,151
Notes receivable		71,771			-
Accounts payable and accrued expenses		79,345			29,872
Related party payable		(11,869	)		28,514
Net cash provided by (used in) operating activities		7,413			(421,189	)

Cash flows from investing activities:
Repurchase and retirement of common stock		-			(80,000	)
Notes receivable investment		-			(100,000	)
Net cash used in investing activities		-			(180,000	)

Cash flows from financing activities
Proceeds from convertible notes payable		-			625,500
Net cash provided by financing activities		-			625,500

Net increase (decrease) in cash		7,413			24,311
Cash - beginning of the year		17,881			18,975
Cash - end of the year	$	25,294		$	43,286

Supplemental disclosures:
Interest paid	$	-		$	-
Income taxes	$	-		$	-

Non-cash transactions:
Preferred stock dividends declared	$	25,150		$	25,150
Discount on convertible note payable	$	-		$	695,000
Issuance of common stock from shares to be issued	$	-		$	160,000

The accompanying notes are an integral part of these financial statements.

Table of Contents

GRIDIRON BIONUTRIENTS, INC.

Notes to Consolidated Financial Statements (Unaudited)

February 28, 2021

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

Gridiron BioNutrients, Inc. (the “Company” or “Gridiron”) was formed under the laws of the state of Nevada on July 20, 2017 to develop and distribute a retail line of health water infused with probiotics and minerals.

The Company is currently developing products which contain a proprietary blend of humic and fulvic acid, trace minerals, probiotics, electrolytes, cannabidiol (CBD) within an alkaline of pH10. Gridiron has secured the rights to this proprietary formulation through its CEO, Timothy Orr (Verbal Agreement). Timothy Orr provided the formulation in connection with his receipt of 105,519 shares of common stock from the Company on October 9, 2017.

Gridiron has the exclusive right(s) to develop CBD products with this formulation. However, Gridiron is limited to developing only CBD products with this formulation and as such does not have any rights to develop products that do not contain CBD with this formulation.

The Company has elected an August 31^st year end.

On December 22, 2020, the Company filed Articles of Amendment to its Articles of Incorporation, as amended, which were effective on January 8, 2021 (the “Effective Date”), which effected a three hundred eight for one (308:1) reverse stock split of its outstanding common stock. Previously, on December 4, 2020 the Company filed a definitive Information Statement on Schedule 14C with the SEC notifying its stockholders that on December 2, 2020, the holders of a majority of its outstanding shares of common stock and the shares Series A Convertible Preferred Stock who were entitled to consent to the action, voting as a single class, executed a written consent in lieu of a special meeting of stockholders approving a reverse stock split of the Company’s outstanding common stock of not less than 300:1 and not more than 310:1, with the Company’s board of directors having the discretion as to when such reverse stock split would be effected (on or prior to December 2, 2021) and the exact ratio of the reverse stock split to be set at a whole number within the above range as determined by the board of directors in its sole discretion. On December 17, 2020, in accordance with such authority, the board of directors fixed the exact ratio of the reverse stock split.

Acquisition and Reverse Merger

On October 10, 2017, the Company completed a reverse merger with My Cloudz, Inc. (“My Cloudz”) pursuant to which the Company merged into My Cloudz on October 10, 2017. Under the terms of the merger, the Company shareholders received 227,273 common shares of My Cloudz common stock such that the Company shareholders received approximately 57% of the total common shares issued and outstanding following the merger. Due to the nominal assets and limited operations of My Cloudz prior to the merger, the transaction was accorded reverse recapitalization accounting treatment under the provision of Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 805 whereby the Company became the accounting acquirer (legal acquiree) and My Cloudz was treated as the accounting acquiree (legal acquirer). The historical financial records of the Company are those of the accounting acquirer (GridIron) adjusted to reflect the legal capital of the accounting acquiree (My Cloudz). As the transaction was treated as a recapitalization, no intangibles, including goodwill, were recognized. Concurrent with the effective date of the reverse recapitalization transaction, the Company adopted the fiscal year end of the accounting acquirer of August 31.

At the date of acquisition, My Cloudz had $3,972 of cash, $1,105 of accounts payable and a related party payable of $75,907. Book values for all assets acquired and liabilities assumed equaled fair values as of the date of acquisition.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The Company’s unaudited consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern, which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business, and in accordance with the instructions for Form 10-Q and Article 10 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended. Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.

In the opinion of management, the consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

The results for the three and six-months ended February 28, 2021 are not necessarily indicative of the results of operations for the full year. These unaudited financial statements and related footnotes should be read in conjunction with the amended consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2020 filed with the Securities and Exchange Commission on December 15, 2020.

Reclassifications

Certain prior year amounts have been reclassified for comparative purposes to conform to the current-year financial statement presentation. These reclassifications had no effect on previously reported results.

Table of Contents

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. Estimates are used when accounting for fair value calculations related to embedded conversion features of outstanding convertible notes payable.

Cash

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes. The Company had $25,294 and $17,881 of cash as of February 28, 2021 and August 31, 2020, respectively.

Revenue recognition

The Company recognizes revenue under ASU No. 2014-09, ”Revenue from Contracts with Customers (Topic 606),” (“ASC 606”). The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer.

Revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration that an entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery.

Fair Value of Financial Instruments

Fair value of certain of the Company’s financial instruments including cash, prepaid expenses, accounts payable, accrued expenses, notes payable, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.

Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.

Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.

Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.

As discussed in Note 9 – Derivative Liability, the Company valued its derivative liability using Level 3 inputs as of February 28, 2021 and August 31, 2020. The Company did not identify any additional assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with ASC 825-10 as of February 28, 2021 and August 31, 2020.

Table of Contents

Derivative Liabilities

The Company generally does not use derivative financial instruments to hedge exposures to cash flow or market risks. However, certain other financial instruments, such as warrants and embedded conversion features on the convertible debt, are classified as derivative liabilities due to protection provisions within the agreements. Convertible notes payable are initially recorded at fair value using the Monte Carlo model and subsequently adjusted to fair value at the close of each reporting period. The preferred stock warrants are initially recorded at fair value using the Black Scholes model and subsequently adjusted to fair value at the close of each reporting period. The Company accounts for derivative instruments and debt instruments in accordance with the interpretive guidance of ASC 815, ASU 2017-11, and associated pronouncements related to the classification and measurement of warrants and instruments with conversion features.

Income Taxes

Income taxes are accounted for under the assets and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Use of net operating loss carry forwards for income tax purposes may be limited by Internal Revenue Code section 382 if a change of ownership occurs.

Principals of Consolidation

The consolidated financial statements represent the results of Gridiron BioNutrients, Inc, its wholly owned subsidiary, Gridiron Ventures and the assets, processes, and results therefrom. All intercompany transactions and balances have been eliminated. All financial information has been prepared in conformity with accounting principles generally accepted in the United States of America.

Property and Equipment

Property and equipment are carried at cost. Expenditures for maintenance and repairs are expensed in the period incurred. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period.

Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets and the modified accelerated cost recovery system for federal income tax purposes. The estimated useful lives of depreciable assets are:

Estimated

Useful Lives

Computer and other equipment

3 years

Vehicle

5 years

The Company’s property and equipment consisted of the following as of February 28, 2021 and August 31, 2020:

	February 28, 2021			August 31, 2020
Computer Equipment	$	1,569		$	1,569
Other		3,587			3,587
Accumulated depreciation		(3,960	)		(3,144	)
Net book value	$	1,196		$	2,012

Depreciation expense was $387 and $653 for three months ended February 28, 2021 and February 29, 2020, respectively, and $816 and $1,307 for six months ended February 28, 2021 and February 29, 2020, respectively.

Inventories

Inventories consist of raw materials and T-free distillate and are stated at the lower of cost or net realizable value using the first‑in, first‑out method. The Company periodically assesses the recoverability of its inventory and reduces the carrying value of the inventory when items are determined to be obsolete, defective or in excess of forecasted sales requirements. Inventory write‑downs for excess, defective and obsolete inventory are recorded as impairment expense in the accompanying statement of operations. The Company wrote-off $-0- and $35,118 of obsolete inventory or inventory below market value for the three months ended February 28, 2021 and February 29, 2020, respectively, and $-0- and $37,000 for the six months ended February 28, 2021 and February 29, 2020, respectively.

A summary of the Company’s inventory as of February 28, 2021 and August 31, 2020 are as follows:

Type	February 28, 2021		August 31, 2020
Raw Materials	$	450	$	450
T-free Distillate		36,000		37,000

Total Inventory	$	36,450	$	37,450

Table of Contents

Basic Income (Loss) Per Share

Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.

The preferred conversion and warrants would account for approximately 167,000 additional shares, the convertible debt would account for approximately 1,000,000 additional shares along with the 188,616 outstanding shares at February 28, 2021. The Company calculates diluted earnings per share by dividing the Company’s net income available to common shareholders less preferred dividends by the diluted weighted average number of shares outstanding during the period. The Company’s convertible notes and warrants are excluded from the computation of diluted earnings per share as they are anti-dilutive due to the Company’s operating losses for the six months ended February 28, 2021 and February 29, 2020.

Dividends

As discussed in Note 7 – Stockholders Equity (Deficit), during the year ended August 31, 2018, the Company issued preferred stock which accrues dividends at a rate of 5% annually. There was $99,145 and $73,995 of dividends payable at February 28, 2021 and August 31, 2020, respectively. The dividends have not been declared and are accrued in the accompanying consolidated balance sheets as a result of a contractual obligation in the Company’s preferred stock offering.

Advertising Costs

The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising costs totaling $156 and $466 during the three months ended February 28, 2021 and February 29, 2020, respectively, and $365 and $1,837 during the six months ended February 28, 2021 and February 29, 2020, respectively.

Stock-Based Compensation

The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718. The Company issues restricted stock to employees and consultants for their services. Cost for these transactions are measured at the fair value of the equity instruments issued at the date of grant. These shares are considered fully vested and the fair market value is recognized as expense in the period granted. The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services. For agreements requiring future services, the consulting expense is to be recognized ratably over the requisite service period.

There was $-0- stock-based compensation during the three and six months ended February 28, 2021 and February 29, 2020.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include (a) affiliates of the Company; (b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; (d) principal owners of the Company; (e) management of the Company; (f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a) the nature of the relationship(s) involved; (b) description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Table of Contents

Recently Issued Accounting Standards

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, “Disclosure Update and Simplification,” amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. This analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule was effective as of November 5, 2018. The adoption of this final rule did not have a material impact on the financial statements.

In February 2018, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-02, Income Statement Reporting, Comprehensive Income (Topic 220). Effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The Company has adopted 2018-02 and determined there was no material impact on the financial statements.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, as part of its Simplification Initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The guidance is effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effect ASU 2019-12 will have on the consolidated financial statements and related disclosures.

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluation the impact this ASU will have on its consolidated financial statements.

Management believes recently issued accounting pronouncements will have no impact on the financial statements of the Company.

Accounts Receivable

Accounts receivable balances are established for amounts owed to the Company from its customers from the sale of products. The Company closely monitors the collectability of outstanding accounts receivable and provide an allowance for doubtful accounts based on estimated collections of outstanding amounts. The Company evaluated the accounts receivable and determined no collection loss reserve was necessary. There were $-0- outstanding accounts receivable as of February 28, 2021 and August 31, 2020.

Trademark

Trademark costs are capitalized as incurred to the extent the Company expects the costs incurred to result in a trademark being awarded. The trademarks are deemed to have an indefinite life and are reviewed for impairment loss considerations annually. As of February 28, 2021 and August 31, 2020, the Company had trademarks totaling $1,680.

NOTE 3 – GOING CONCERN

The Company’s financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company had limited revenue and net income of $320,681 for the six months ended February 28, 2021. The net income includes a non-cash $572,701 gain from change in fair value of derivative liability. The Company has working capital deficit of $2,392,309 and an accumulated deficit of $3,548,396 as of February 28, 2021. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The ability of the Company to fully commence its operations is dependent upon, among other things, obtaining additional financing to continue operations, and execution of its business plan. In response to these concerns, management plans to fund operations through additional debt and equity financing. Debt instruments may be convertible or non-convertible and will vary based on the Company’s needs and financing options available at such times. There can be no assurance that management’s plan will be successful.

Table of Contents

NOTE 4 – NOTES RECEIVABLE

On January 24, 2020, the Company received a promissory note from a supplier, Notis Global, Inc. (“NGBL”). The $112,500 note was issued with an original issue discount of $12,500 or 12.5%. NGBL will repay the promissory note with 12.5% of its sales of derivative products of hemp planted and harvested in 2020. In addition, once the promissory note has been repaid, the Company shall be paid an aggregate of 3.75% of the 2020 derivative products revenues sold by the supplier. The original issue discount is amortized through the term of the note. At August 31, 2020, the Company evaluated the promissory noted under ASU 2016-16, “Financial Instruments – Credit Losses, (Topic 326)” and determined the entire balance was impaired. The Company reported an $100,000 impairment charge at August 31, 2020.

On April 27, 2020, the Company entered into a Participation Agreement, effective April 27, 2020, with Libertas Funding, LLC, a Connecticut Limited Liability Company (“Libertas”), pursuant to which Libertas offered and the Company accepted to participate with Future Receivables in Purchase Agreement(s) with qualifying merchants, specifically QSI Holding Company, a Delaware Corporation (“QSI”). The Company’s participation buy-in amount was $200,000 with a participation purchase of $264,000 that is estimated to result in weekly payments to the Company for a minimum period of six months or until the full participation purchase amount has been paid. The $200,000 buy-in was recorded as a Note receivable on the accompanying consolidated balance sheets. On September 1, 2020, Libertas renegotiated this agreement and the Company will receive weekly payments for $4,921 and extended the term to 38 weeks. The previous weekly payment was $6,984. The unpaid balance was $61,081 and $132,852 at February 28, 2021 and August 31, 2020, respectively.

In addition, on April 29, 2020, under the Libertas Participation Agreement, the Company received 45,053 Warrants of QSI Holding Company, a private company, (“QSI Warrants”) to purchase common stock priced at $3.111 per share for common stock par value $0.00001 expiring the 7th anniversary after the issue date. Upon issuance, the Company valued the warrants using the Black Scholes model yielding a total value of $58,443. The Company used the following assumptions upon measurement: QSI Holding Company value per common share of $3.4520, a life of 7 years, an exercise price of $3.111, a risk-free rate of 0.56% and volatility of 32%. In addition, the Company recorded a discount of $58,443 and will record income over the 7-year life of the warrants. The warrants are recorded as an equity investment in the accompanying consolidated balance sheets for $6,957 and $2,783 at February 28, 2021 and August 31, 2020, respectively. The Company recorded other income of $2,087 and $-0-, respectively for the three months ended February 28, 2021 and February 29, 2020, respectively, and $4,174 and $-0-, respectively for the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying statement of operations.

NOTE 5 – NOTES PAYABLE

Short-Term Notes Payable

On September 14, 2017, the Company issued a $10,000 promissory note to a limited liability company. The loan bears interest at 5% and has a maturity date of September 15, 2018. The unpaid balance including accrued interest was $11,730 and $11,482 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note.

On May 31, 2018, the Company issued a $39,500 promissory note to a company. The loan bears interest at 0% and has a maturity date of November 30, 2018. During March 2020, it was discovered the promissory note was fully paid-off on August 6, 2018 and inadvertently recorded as an operating expense for the year ended August 31, 2018. At February 29, 2020, the Company wrote-off the promissory note to operating expense. The unpaid balance was $-0- at February 28, 2021 and August 31, 2020.

Convertible Notes Payable

On August 27, 2019, the Company signed a convertible promissory note with an investor. The $30,000 note was issued with an original issue discount of $3,000 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 25% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on February 27, 2020. The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance. After February 27, 2020, the payment premium increases to 125% of the principal and interest outstanding and if in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. The unpaid balance including accrued interest was $49,548 and $46,870 at February 28, 2021 and August 31, 2020, respectively. On March 3, 2020, the Company was granted an extension of payment terms to August 1, 2020. The five-month extension does not modify any terms in the convertible promissory note. The Company is in default with the repayment terms of the note.

On November 25, 2019, the Company signed a convertible promissory note with an investor. The $140,000 note was issued with an original issue discount of $14,000 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on May 25, 2020. The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance. If in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. On May 27, 2020, the Company was granted an extension of payment terms to November 30, 2020. The six-month extension does not modify any terms in the convertible promissory note. The unpaid balance including accrued interest was $225,073 and $212,577 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note.

Table of Contents

On January 27, 2020, the Company signed a convertible promissory note with an investor. The $555,000 note was issued with an original issue discount of $55,500 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on July 27, 2020. The note has a prepayment penalty of 115% of the principal and interest outstanding if repaid more than 30 days after note issuance. If in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. The unpaid balance including accrued interest was $875,014 and $825,475 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note.

On April 27, 2020, the Company signed a convertible promissory note with an investor. The $259,615 note was issued with an original issue discount of $57,115 and bears interest at -0-% per year. The Company recorded the self-amortizing convertible promissory note using the effective interest rate method to calculate the loan payable at $202,500 and accrued interest at $57,115. The note requires nine equal payments due starting June 15, 2020 for $28,846. In the event the Company fails to make the $28,846 installment payment by the 15^th day of each designated month and/or fails to cure any missed installment payment within five (5) calendars days following the due date, or the Company defaults, the defaulted amount owed shall be 130% of the total outstanding balance owed by the Company. The default interest rate for missing an installment payment shall be 18% and the conversion into common stock shall be at a price of $0.02 per common stock. The note principal and interest are convertible into shares of common stock at the lower of $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matures on February 21, 2021. The Company made the first payment on June 15, 2020 for $28,846 and a partial payment of $10,000 on July 15, 2020. The original issue discount is amortized through the term of the note. The unpaid principal and interest balance was $299,590 and $287,665 February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note.

The conversion features meet the definition of a derivative liability instrument because the conversion rate is variable and therefore does not meet the “fixed-for-fixed” criteria outlined in ASC 815-40-15. As a result, the conversion features of the notes are recorded as a derivative liability at fair value and marked-to-market each period with the changes in fair value each period charged or credited to other income (expense). See Note 9 - Derivative Liability, for a further discussion.

At February 28, 2021 and August 31, 2020, the outstanding principal balances of the convertible notes payable, net of debt discount was $945,769 and $831,170, respectively. The Company recorded interest accretion on the debt discount of $34,088 and $167,069 for the three months ended February 28, 2021 and February 29, 2020, respectively, and $114,599 and $184,031 for the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying consolidated statements of operations.

NOTE 6 – RELATED PARTY TRANSACTIONS

As of February 28, 2021, and August 31, 2020, the Company owed $61,600 and $73,469, respectively to its President and Director. The balance due is recorded in related party payable in the accompanying consolidated balance sheets.

NOTE 7 – STOCKHOLDERS’ EQUITY

Preferred Stock

There were 8,480,000 preferred shares issued and outstanding as of February 28, 2021 and August 31, 2020.

Common Stock

On January 8, 2021, a 308-to-1 reverse stock split was declared effective. In accordance with the terms of all such instruments, the conversion ratio of the Company’s outstanding Series A Convertible Preferred Stock and its various convertible promissory notes, together with the exercise price of its outstanding warrants, were proportionally adjusted to give effect to the reverse stock split.

The Company is authorized to issue up to 200,000,000 shares of $0.001 par value common stock.

On, January 28, 2020, the Company entered into an agreement to repurchase 252,833 restricted shares of the Company’s common stock from an investor. The Company paid $80,000 or $0.3164 per share and immediately retired the shares.

There were 188,616 common shares issued and outstanding as of February 28, 2021 and August 31, 2020.

NOTE 8 – COMMITMENTS AND CONTINGENCIES

The Company could become a party to various legal actions arising in the ordinary course of business. Matters that are probable of unfavorable outcomes to the Company and which can be reasonably estimated are accrued. Such accruals are based on information known about the matters, the Company’s estimates of the outcomes of such matters and its experience in contesting, litigating and settling similar matters. As of the date of this report, there are no pending legal proceedings to which the Company is a party or of which any of their property is the subject, nor are there any such proceedings known to be contemplated by governmental authorities.

Table of Contents

NOTE 9 – DERIVATIVE LIABILITY

Preferred Stock Warrants

During the year ended August 31, 2018, the Company issued a total of 27,532 warrants to purchase common stock as part of its preferred stock offering. The warrants are exercisable for a period of three years at $50.82 per share. Additionally, the warrant holder is entitled to a cashless exercise after nine months from issuance in which the holder is entitled to receive a number of shares equal to: [A] the number of outstanding warrant shares under the original issuance multiplied by [B] the greater of the trailing five day volume weighted average price less [A] the number of outstanding warrant shares under the original issuance multiplied by [C] the exercise price of the warrant under the original issuance divided by [D] the lesser of the arithmetic average of the volume weighted average price during the five trailing trading days or the volume weighted average price for the trading day immediately prior to the cashless exercise election. For clarity, the resulting formula is [(A x B) – (A x C)] / D.

The Company analyzed the conversion features of the cashless exercise feature in the warrants issued for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded features should be classified as a derivative liability because the exercise price of these warrants are subject to a variable rate. The Company has determined that warrants are not considered to be solely indexed to the Company’s own stock and is therefore not afforded equity treatment. In accordance with ASC 815, the Company has recorded a derivative liability.

Upon issuance, the Company valued the derivative using a Black-Scholes model yielding a total value of $674,012 which was expensed during the year ended August 31, 2018. The Company used the following assumptions upon initial measurement: value per common share of $27.72, a remaining life of 3.0 years, an exercise price of $50.82, a risk-free rate of 2.77% and volatility of 195%.

The Company revalued the derivative liability as of February 28, 2021 and recorded income of $7,735 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon the measurement: value per common share of $2.25, a remaining life of .42 years, an exercise price of $50.82, a risk-free rate of 0.05% and volatility of 265%.

The following table summarizes all stock warrant activity for the six months ended February 28, 2021:

	Warrants		Weighted- Average Exercise Price Per Share
Outstanding, August 31, 2020		27,532	$	50.82
Granted		-		-
Exercised		-		-
Forfeited		-		-
Expired		-		-
Outstanding, February 28, 2021		27,532	$	50.82

The following table discloses information regarding outstanding and exercisable warrants at February 28, 2021:

Outstanding

Exercisable

Exercise

Prices

Number of

Warrant Shares

Weighted Average

Exercise Price

Weighted Average

Remaining Life

(Years)

Number of

Warrant Shares

Weighted Average

Exercise Price

50.82

27,532

50.82

0.66

27,532

50.82

Convertible Notes Payable

As discussed in Note 5 – Notes Payable, the Company signed various convertible promissory note with an investor as follows:

On August 27, 2019, the Company signed a $30,000 convertible promissory note with an investor. The note principal and interest are convertible into shares of common stock at a 25% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.

The Company analyzed the conversion feature and determine it meets the definition of a derivative liability instrument because the conversion rate is variable and therefore does not meet the “fixed-for-fixed” criteria outlined in ASC 815-40-15. As a result, the conversion features of the notes are recorded as a derivative liability at fair value and marked-to-market each period with the changes in fair value each period charged or credited to other income (expense).

Upon issuance, the Company valued the derivative using a Monte Carlo simulation model yielding a total value of $50,277 which was recorded as a derivative liability during the year ended August 31, 2019. The Company used the following assumptions upon initial measurement: value per common share of $2.74, a remaining life of 6 months, an exercise price of $1.30, a risk-free rate of 1.98% and volatility of 287%. In addition, the Company calculated the derivative discount as the difference between the conversion price and the fair market value of the Company’s common stock on the date of issuance. The Company recorded an original issue discount of $3,000 and a derivative discount of $27,000 which aggregated a total discount of $30,000 and was recorded as a discount in the accompanying consolidated balance sheet. On the date of issuance, a net loss of $23,277 was recorded in the accompanying statement of operations.

The Company revalued the derivative liability as of February 28, 2021 and recorded expense of $19,747 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 1 month, an exercise price of $1.66, a risk-free rate of .04% and volatility of 162%.

Table of Contents

On November 25, 2019, the Company signed a $140,000 convertible promissory note with an investor. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.

Upon issuance, the Company valued the derivative using a Monte Carlo simulation model yielding a total value of $172,608 which was recorded as a derivative liability during the three months ended November 30, 2019. The Company used the following assumptions upon initial measurement: value per common share of $1.54, a remaining life of 6 months, an exercise price of $0.93, a risk-free rate of 1.61% and volatility of 275%. In addition, the Company calculated the derivative discount as the difference between the conversion price and the fair market value of the Company’s common stock on the date of issuance. The Company recorded an original issue discount of $14,000 and a derivative discount of $126,000 which aggregated a total discount of $140,000 and was recorded as a discount in the accompanying consolidated balance sheet. On the date of issuance, a net loss of $46,608 was recorded in the accompanying statement of operations.

The Company revalued the derivative liability as of February 28, 2021 and recorded expense of $98,879 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 1 month, an exercise price of $1.44, a risk-free rate of .04% and volatility of 162%.

On January 27, 2020, the Company signed a $555,000 convertible promissory note with an investor. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.

Upon issuance, the Company valued the derivative using a Monte Carlo simulation model yielding a total value of $929,300 which was recorded as a derivative liability during the three months ended February 29, 2020. The Company used the following assumptions upon initial measurement: value per common share of $6.65, a remaining life of 6 months, an exercise price of $3.13, a risk-free rate of 1.57% and volatility of 281%. In addition, the Company calculated the derivative discount as the difference between the conversion price and the fair market value of the Company’s common stock on the date of issuance. The Company recorded an original issue discount of $55,500 and a derivative discount of $499,500 which aggregated a total discount of $555,000 and was recorded as a discount in the accompanying consolidated balance sheet. On the date of issuance, a net loss of $429,800 was recorded in the accompanying statement of operations.

The Company revalued the derivative liability as of February 28, 2021 and recorded expense of $383,074 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 1 month, an exercise price of $1.44, a risk-free rate of 0.04% and volatility of 162%.

On April 27, 2020, the Company signed a $259,615 convertible promissory note with an investor. The note principal and interest are convertible into shares of common stock at $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.

Upon issuance, the Company valued the derivative using a Monte Carlo simulation model yielding a total value of $587,772 which was recorded as a derivative liability during the three months ended May 31, 2020. The Company used the following assumptions upon initial measurement: value per common share of $3.17, a remaining life of 9 months, an exercise price of $1.28, a risk-free rate of 0.17% and volatility of 304%. In addition, the Company calculated the derivative discount as the difference between the conversion price and the fair market value of the Company’s common stock on the date of issuance. The Company recorded an original issue discount of $57,115 and a derivative discount of $202,500 which aggregated a total discount of $259,615 and was recorded as a discount in the accompanying consolidated balance sheet. On the date of issuance, a net loss of $385,272 was recorded in the accompanying statement of operations.

The Company revalued the derivative liability as of February 28, 2021 and recorded expense of $155,909 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 3 months, an exercise price of $1.44, a risk-free rate of 0.04% and volatility of 162%.

Derivative Liability Summary

As of February 28, 2021 and August 31, 2020, the Company had derivative liabilities totaling $881,779 and $1,454,480, respectively, in the accompanying consolidated balance sheet, and (gain) loss on change in fair value of the derivative liability of ($665,343) and $909,090 for the three months ended February 28, 2021 and February 29, 2020, respectively, and ($572,701) and $1,055,317 for the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying consolidated statement of operations. In addition, the Company amortized $34,088 and $167,069 to interest accretion during the three months ended February 28, 2021 and February 29, 2020, respectively, and $114,599 and $184,031 to interest accretion during the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying consolidated statement of operations for the derivative convertible notes payable.

Table of Contents

NOTE 10 – MATERIAL CONTRACTS

On September 4, 2019, the Company signed an initial non-binding letter of intent with NanoPeak Performances, LLC with a subsequent addendum for the sale of the majority of its existing inventory as well as the exclusive license to Gridiron intellectual property and other intangible assets. During October 2019, NanoPeak Performances paid a $25,000 non-refundable deposit on the transaction. The Company recorded the deposit in accrued expenses in accompanying consolidated balance sheet. On February 29, 2020, the Company determined the non-binding letter of intent terminated and wrote-off the $25,000 non-refundable deposit other income.

In November 2019, the Company made a strategic decision to expand into the cannabinoids (CBD) oil extraction business and on or about November 27, 2019, the Company signed a Supply Agreement with Notis Global, Inc. (“NGBL”), a grower to purchase 10,000 pounds of industrial hemp (biomass) and was processed into crude during the three months ended February 29, 2020. During November 2019, the Company paid $100,000 to the supplier and recorded the purchase in inventory in the accompanying consolidated balance sheet. During January 2020, the Company purchased an additional 30,000 pounds of industrial hemp (biomass) for $5 a pound or $150,000 under the agreement. On August 31, 2020, the Company wrote-down $115,000 of its recently purchased industrial hemp (biomass) raw material to fair market value of $35,000.

On December 13, 2019, the Company signed a Toll Processing Agreement with a corporation to process industrial hemp (biomass) into the CBD product. The contract is valued at $100,000. During the year ending August 31, 2020, the Company spent $72,500 to fulfill the contract.

On January 24, 2020, the Company signed a Collaboration Agreement with a supplier, Notis Global, Inc. (“NGBL”), to explore and consider potential business opportunities for the parties within various segments of the hemp CBD supply chain including cultivation, extraction and purification and retail products. As consideration for the services to be provided by the Company, NGBL shall issue to the Company 2.5 billion shares of NGBL restricted common stock. Either party may terminate this agreement at any time upon 10 business days’ written notice. The equity investment is valued at $250,000 or 20% ownership of NGBL, however, NGBL is not current with their filing with the Securities and Exchange Commission and do not have the authorized shares to fulfill the agreement. The Company evaluated the shares of NGBL and determined there was $-0- value at February 28, 2021.

NOTE 11 – SUBSEQUENT EVENTS

On April 9, 2021 Company entered into an Exchange Agreement with Calvary Fund Management, LLC (“Calvary”) pursuant to which it agreed to issue Calvary 2,694,514 shares of its newly designated Series B Convertible Preferred Stock (the “Series B Preferred”) in exchange (the “Exchange”) for (i) 8,480,000 shares of its Series A Convertible Preferred Stock (the “Series A Preferred”), (ii) outstanding common stock purchase warrants (the “Warrants”), and (iii) all principal and accrued interest due under outstanding convertible promissory notes (the “Convertible Notes”, and together with the Series A Preferred and the Warrants, the “Calvary Securities”). The closing of the Exchange (the “Closing”) will occur following the satisfaction or waiver of the conditions set forth in the Exchange Agreement. On the Closing date, subject to the terms and conditions of the Exchange Agreement, the Company will issue the Series B Preferred to Calvary in exchange for the Calvary Securities (which will be cancelled and retired) in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on exemptions provided pursuant to Section 3(a)(9) of the Securities Act.

The Series B Preferred Designations designated 2,694,514 shares of the Company’s blank check preferred stock as Series B Preferred Stock. In addition to rights granted to holders of Series B Preferred Stock under the Nevada Revised Statues, each holder will be entitled to the whole number of votes equal to the number of shares of common stock into which such holder’s Series B Preferred Stock would be convertible on the record date for the vote or consent of stockholders, and shall otherwise have voting rights and powers equal to the voting rights and powers of the common stock. Once issued, the shares of Series B Preferred Stock are transferrable by the holder in the holder’s sole option without the consent of the Company, subject to compliance with Section 5 of the Securities Act.

The Series B Preferred Stock will rank senior to all other classes of the Company’s capital stock and has a stated value of $1.30 per share (the “Stated Value”). Subject only to the liquidation rights of the holders of Series B Preferred Stock that is then currently issued and outstanding, upon the liquidation, dissolution or winding up of the business of the Company, whether voluntary or involuntary, the Series B Preferred Stock is entitled to receive an amount per share equal to the Stated Value and then receive a pro-rata portion of the remaining assets available for distribution to the holders of common stock on an as-converted to common stock basis.

From and after the Closing date, cumulative dividends on each share of Series B Preferred Stock will accrue, on a quarterly basis in arrears, at the rate of 10% per annum on the Stated Value, plus all dividends, whether declared or not, on such share of Series B Preferred Stock (the “Additional Amount”) thereon. All accrued dividends on each share of Series B Preferred Stock are to be paid upon conversion of the Series B Preferred Stock for which the applicable dividend is due. At the option of the Company dividends may be paid in cash or shares of common stock. Each holder of Series B Preferred Stock will also be entitled to receive dividends or distributions on each share of Series B Preferred Stock on an “as converted” into common stock basis when and if dividends are declared on the common stock by the Company’s Board of Directors. Dividends may be paid in cash or property, as determined by the Board of Directors.

Subject to the beneficial ownership limitations described below, at any time after the Closing date, each share of Series B Preferred Stock will be convertible at the holder’s option into validly issued, fully paid and non-assessable shares of common stock at a conversion rate (the “Conversion Rate”) determined by dividing the Conversion Amount of such share of Series B Preferred Stock by the conversion price, which is (i) $1.30 or (ii) 75% of the price paid per share by investors in any subsequent offering of the Company’s common stock or common stock equivalents, subject to adjustment as provided herein, subject to adjustment as set forth below (the “Conversion Price”). The Conversion Amount is defined as the Stated Value plus the Additional Amount and any accrued and unpaid late charges with respect to such Stated Value and Additional Amount as of such date of determination. In addition, the shares of Series B Preferred Stock will be convertible at the holder’s option at the Conversion Price any time during the period commencing on the date of the occurrence of a Triggering Event (as defined in the Series B Preferred Designations). A holder of Series B Preferred Stock will not be able to convert the shares into shares of common stock to the extent such conversion or exercise would cause the holder, together with its affiliates, to beneficially own a number of shares of common stock which would exceed 4.99% of the Company’s then outstanding shares of our common stock following such exercise or conversion, subject to a waiver by the holder upon 61 days’ prior notice to the Company.

The Conversion Price and the number of shares of common stock issuable upon conversion of the Series B Preferred Stock will be subject to pro-rata adjustment for stock splits, dividends and similar corporate events. In addition, if on or after April 9, 2021, the execution date of the Exchange Agreement, the Company issues or sells, or is deemed to have issued or sold, any shares of common stock, excluding certain specified excluded securities for a consideration per share (the “New Issuance Price”) less than a price equal to the Conversion Price in effect immediately prior to such issue or sale or deemed issuance or sale, then, immediately after such dilutive issuance, the Conversion Price then in effect shall be reduced to the New Issuance Price.

The Series B Preferred Designations or any provision hereof (other than the beneficial ownership limitation set forth above) may be modified or amended or the provisions hereof waived with the written consent of the Company and either (i) the holders of a majority of the Series B Preferred Stock then currently outstanding, which must include Cavalry as long as Cavalry (or any of its affiliates) owns at least 5% of the Series B Preferred Stock issued pursuant to the Exchange Agreement, or (ii) Cavalry as long as Cavalry (or any of its affiliates) owns at least 5% of the Series B Preferred Stock issued pursuant to the Exchange Agreement.

The Company has evaluated all other events occurring subsequently to these financial statements through April 14, 2021 and determined there were no other items to disclose.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion of our financial condition and results of operations for the three and six months ended February 28, 2021 and February 29, 2020 should be read in conjunction with the consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements because of several factors, including those set forth under the Part I, Item 1A, Risk Factors and Business sections in our Annual Report on Form 10-K for the fiscal year ended August 31, 2020, as filed with the SEC on December 15, 2020, our Current Report on Form 8-K as filed with the SEC on April 12, 2021, this report, and our other filings with the SEC. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance, our anticipated growth and trends in our businesses, and other characterizations of future events or circumstances are forward-looking statements. Such statements are based on our current expectations and could be affected by the uncertainties and risk factors described throughout this report.

Overview

Our products are marketed and available through our website www.gridironMVP.com. We intend to engage a distribution partner that has a sufficient broker network and co-packer/manufacturer in order distribute our products through several channels. We believe there will be an increasing demand for enhanced and functional products in 2021 as consumers look for healthy alternatives to enhance their lifestyle. We expect our brand to capitalize on this and potential consumer demand. We plan to continue to look for opportunities with industrial hemp growers, processors that we can engage in a tolling and/or collaboration agreement. We believe these types of relationships could assist in stabilizing our raw material supply chain as well as give us positive exposure within the marketplace.

Our current business model is in an industry which is highly competitive and most of our competitors are better capitalized than we are and have established markets with greater brand recognition. Our operations do not generate sufficient revenues to pay our operating expenses, and, as discussed below, we do not have ready access to the capital necessary to compete effectively in our segment. While we continue to explore opportunities to expand our current business model, our management has also begun exploring possible opportunities for the Company involving mergers, acquisitions or other business combination transactions in an effort to diversify our business. We are not currently a party to any agreement or understandings with any third parties, and there are no assurances even if our management locates an opportunity which it believes will be in the best interests of our stockholders what we will ever consummate such a transaction. Accordingly, investors should not place undue reliance on these efforts.

Cash Flows

Our financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. We have not yet established an ongoing source of revenues sufficient to cover our operating costs. Our ability to continue as a going concern is dependent on our company obtaining additional capital to fund operating losses until we become profitable. If we are unable to obtain additional capital, we could be forced to significantly curtail or cease operations.

We have only realized nominal revenues from our business. In the next 12 months, we plan to identify business to whom we can license and/or distribute our brand and product(s) as well as seek additional opportunities to continue as a going concern.

COVID-19

In December 2019, a novel strain of COVID-19 was reported in China. Since then, the COVID-19 has spread globally including across North America and the United States. The spread of COVID-19 from China to other countries has resulted in the World Health Organization (WHO) declaring the outbreak of COVID-19 as a “pandemic,” or a worldwide spread of a new disease, on March 11, 2020. Specifically, we caution that our business could be materially and adversely affected by the risks, or the public perception of the risks, related to the outbreak of COVID-19. To date, COVID has directly impacted the ability we have to participate in trade show events and other in-person marketing. The risk of a pandemic, or public perception of the risk, could cause customers to avoid public places, including retail properties, and could cause temporary or long-term disruptions in our supply chains and/or delays in the delivery of our inventory to customers. Further, such risks could also adversely affect retail customers’ financial condition, resulting in reduced spending on premium products.

Critical Accounting Policies

Please refer to Note 2 - Summary of Significant Accounting Policies in the accompanying Notes to the Consolidated Financial Statements.

Results of Operations for the Three Months Ended February 28, 2021 and February 29, 2020

Overview. We had revenues of $-0- for the three months ended February 28, 2021 and February 29, 2020. We incurred a net income (loss) of $557,950 and ($1,629,635) for the three months ended February 28, 2021 and February 29, 2020, respectively. The decrease in net loss of $2,187,585 is attributable to the factors discussed below.

Revenues. We had -0- revenues from operations for the three months ended February 28, 2021 and February 29, 2020. The extent to which, and the amount of revenues which may be generated from our future business operations and activities is unknown.

Gross Margin. We had -0- cost of revenue for the three months ended February 28, 2021 and February 29, 2020.

Expenses. Our operating expenses were $56,274 and $48,052 for the three months ended February 28, 2021 and February 29, 2020, respectively. The increase of $8,222 was primarily attributable to an approximate $43,000 increase professional fees from higher audit fees and legal fees associated with reverse stock split and a $39,500 promissory note reversal during the three months ended February 29, 2020, offset, by an approximate $18,000 decrease in consulting fees due to an agreed upon fee reduction by our CEO and an approximate $17,000 decrease in other general and administrative and advertising expenses.

Other (Income) Expense. Our total other (income) expense was ($614,224) and $1,581,583 for the three months ended February 28, 2021 and February 29, 2020, respectively. The $2,195,807 decrease in other expenses was attributable to a $1,707,414 decrease in expenses related to our convertible notes payable and preferred stock warrants for the change in fair value of the derivative liability and interest accretion, a $429,800 decrease in debt/equity issuance costs on no new convertible notes during the three months ended February 28, 2021 compared to one new convertible note payables during the three months ended November 30, 2019, a 35,118 decrease in impairment expense from our inventory write-off, a $21,388 decrease in net interest expense on our notes payable, notes receivable and four convertible notes payable and a $2,087 increase in other income.

Table of Contents

Results of Operations for the Six Months Ended February 28, 2021 and February 29, 2020

Overview. We had revenues of $3,080 and $633 for the six months ended February 28, 2021 and February 29, 2020, respectively. We incurred a net income (loss) of $320,681 and ($1,899,484) for the six months ended February 28, 2021 and February 29, 2020, respectively. The decrease in net loss of $2,220,165 is attributable to the factors discussed below.

Revenues. We had revenues from operations of $3,080 and $633 for the six months ended February 28, 2021 and February 29, 2020, respectively. Our revenues for the six months ended February 28, 2021 and February 29, 2020 consisted primarily of our retail line of health water infused with probiotics and minerals and the sale of one liter of T-free distillate. The increase of $2,447 of revenues resulted from the Company selling one liter of T-free distillate during the three months ended November 30, 2020. The extent to which, and the amount of revenues which may be generated from our future business operations and activities is unknown.

Gross Margin. Once cost of revenue and other expenses to generate revenue are considered, we had gross margins of $1,659 and ($919) from our operations for the six months ended February 28, 2021 and February 29, 2020, respectively. The increase of $2,578 was a result of the sale of one liter of T-free distillate during the three months ended November 30, 2020.

Expenses. Our operating expenses were $115,111 and $102,353 for the six months ended February 28, 2021 and February 29, 2020, respectively. The increase of $12,758 was primarily attributable to an approximate $65,000 increase professional fees from higher audit fees and legal fees associated with reverse stock split and a $39,500 promissory note reversal during the three months ended February 29, 2020, offset, by an approximate $28,000 decrease in consulting fees due to an agreed upon fee reduction by our CEO, an approximate $22,000 decrease in other general and administrative and an approximate 1,000 decrease in advertising expense.

Other (Income) Expense. Our total other (income) expense was ($434,133) and $1,796,212 for the six months ended February 28, 2021 and February 29, 2020, respectively. The $2,230,345 decrease in other expenses was attributable to a $1,697,450 decrease in expenses related to our convertible notes payable and preferred stock warrants for the change in fair value of the derivative liability and interest accretion, a $476,408 decrease in debt/equity issuance costs on no new convertible notes during the six months ended February 28, 2021 compared to two new convertible notes payables during the six months ended February 29, 2020, a 37,000 decrease in impairment expense from our inventory write-off, a $15,313 decrease in net interest expense on our notes payable, notes receivable and four convertible notes payable and a $4,174 increase in other income.

Liquidity and Capital Resources

For the six months ended February 28, 2021, we provided net cash of $7,413 from operating activities, primarily attributable to our Participation Agreement with Libertas Funding, LLC. We will require additional capital to continue as a going concern. As set forth in Note 5 to the notes to consolidated financial statements appearing earlier in this report, we are currently in default under the repayment terms of convertible promissory notes in the aggregate amount of $945,769.

Current Assets

We had total assets of $138,658 as of February 28, 2021, which consisted of $25,294 cash, inventory of $36,450, prepaid expenses of $6,000, notes receivable (net of discount) of $61,081 from our Participation Agreement with Libertas Funding, LLC (see Note 4 (Notes Receivable) in the accompanying consolidated financial statements), equity investment (net of discount) of $6,957, equipment of $1,196, (net of accumulated depreciation) and trademarks of $1,680.

Current Liabilities

We had total liabilities of $2,521,134 as of February 28, 2021 consisting of accounts payable and accrued expenses of $522,841, related party payable of $61,600 due our CEO, derivative liability of $881,779, note payable, current portion of $10,000, note payable, convertible notes payable of $945,769 (for further information and details on convertible notes which have been issued, see Note 5 (Convertible Notes Payable) in the accompanying consolidated financial statements) and dividends payable of $99,145.

As described under Note 11 - Subsequent Events appearing earlier in this report, in April 2021 we entered into an Exchange Agreement with Calvary Fund I LP (“Calvary Fund”) pursuant to which we agreed to issue Calvary Fund 2,694,514 shares of our newly designated Series B Convertible Preferred Stock in exchange for (i) 8,480,000 shares of our Series A Convertible Preferred Stock, (ii) outstanding common stock purchase warrants (the “Warrants”), and (iii) all principal and accrued interest due under outstanding convertible promissory notes in the aggregate principal amount of $945,769 (the “Convertible Notes”, and together with the Series A Convertible Preferred Stock and the Warrants, the “Calvary Securities”). On the closing date of the Exchange Agreement, the Company will issue the Series B Convertible Preferred Stock to Calvary Fund in exchange for the Calvary Securities which were canceled and retired.

Cash Requirements

At February 28, 2021, we had a cash balance of $25,294, total current liabilities of $2,521,134. Such cash amount of $25,294 is not sufficient to continue our 12-month plan of operation. We will need to raise capital to realize our 12-month plan of operation and fund our ongoing operational expenses. Additional funding will likely come from equity financing from the sale of our common stock. If we are successful in completing equity financing, existing shareholders will experience dilution of their interest in our Company. We do not have any financing arranged and we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock to fund our 12-month plan of operation and ongoing operational expenses. In the absence of such financing, our business will likely fail. There are no assurances that we will be able to achieve further sales of our common stock or any other form of additional financing.

Table of Contents

Going Concern

To date the Company only generated nominal revenues and consequently has incurred recurring losses from operations. We do not have sufficient funds to support our daily operations for the next twelve (12) months. The ability of the Company to continue as a going concern is dependent on raising capital to fund our business model and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern.

The Company is attempting to commence operations and generate sufficient revenue; however, the Company’s cash position may not be sufficient to support its daily operations. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business model and generate sufficient revenue and its ability to raise additional funds by way of a public or private offering.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 3.

ITEM 4. CONTROLS AND PROCEDURES.

DISCLOSURE CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, our principal executive officer and our principal financial officer are responsible for conducting an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the fiscal year covered by this report. Disclosure controls and procedures means that the material information required to be included in our Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to our company, including any consolidating subsidiaries, and was made known to us by others within those entities, particularly during the period when this report was being prepared. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were not effective as of February 28, 2021 as a result of continuing weaknesses in our internal control over financial reporting as set forth in our Annual Report on Form 10-K for the fiscal year ended August 31, 2020 as filed with the SEC on December 15, 2020.

Changes in Internal Control Over Financial Reporting. There were no changes in the Company’s internal controls over financial reporting during the most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is not currently subject to any legal proceedings. From time to time, the Company may become subject to litigation or proceedings in connection with its business, as either a plaintiff or defendant. There are no such pending legal proceedings to which the Company is a party that, in the opinion of management, is likely to have a material adverse effect on the Company’s business, financial condition or results of operations.

ITEM 1A. RISK FACTORS.

We incorporate by reference the risk factors disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended August 31, 2020 as filed with the SEC on December 15, 2020.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

None.

Table of Contents

ITEM 6. EXHIBITS.

(a) The following Exhibits, as required by Item 601 of Regulation SK, are attached or incorporated by reference, as stated below.

		Incorporated by Reference			Filed or Furnished
No.	Exhibit Description	Form	Date Filed	Number	Herewith
3.1.1	Articles of Incorporation	S-1	4/13/2015	3.1
3.1.2	Certificate of Amendment	10-K	12/15/2017	3.1.2
3.1.3	Certificate of Amendment	8-K	2/21/2018	3.1.1
3.1.4	Certificate of Amendment	8-K	8/16/2018	3.1.1
3.1.5	Certificate of Amendment	8-K	8/16/2018	3.1.2
3.1.6	Certificate of Designation	8-K	8/16/2018	3.1.3
3.1.7	Certificate of Correction	8-K	8/16/2018	3.1.4
3.1.8	Articles of Amendment filed December 22, 2020 effective January 8, 2021	8-K	1/11/21	3.1.8
3.2	Bylaws	S-1	4/13/2015	3.2
10.1	Exchange Agreement dated April 9, 2021 by and between Gridiron BioNutrients, Inc. and Calvary Fund Management, LLP	8-K	4/12/21	10.1
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				Filed
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				Filed
32.1	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002				Filed
101.INS	XBRL Instance Document				Filed
101.SCH	XBRL Taxonomy Extension Schema Document				Filed
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document				Filed
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document				Filed
101.LAB	XBRL Taxonomy Extension Label Linkbase Document				Filed
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document				Filed

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	GRIDIRON BIONUTRIENTS, INC.
	(Name of Registrant)

Date: April 14, 2021	By:	/s/ Timothy Orr
	Name:	Timothy Orr
	Title:	President, Secretary and Treasurer (principal executive officer, principal accounting officer and principal financial officer)

EX-31.1 2 gmvp_ex311.htm CERTIFICATION gmvp_ex311.htm

EXHIBIT 31.1

SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER OF GRIDIRON BIONUTRIENTS, INC.

I, Timothy Orr, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Gridiron BioNutrients, Inc. for the period ended February 28, 2021;

2.	Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.	Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 14, 2021

By:

/s/ Timothy Orr

Timothy Orr

President, Secretary and Treasurer

(principal executive officer,

principal accounting officer and

principal financial officer)

EX-31.2 3 gmvp_ex312.htm CERTIFICATION gmvp_ex312.htm

EXHIBIT 31.2

SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF GRIDIRON BIONUTRIENTS, INC.

I, Timothy Orr, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Gridiron BioNutrients, Inc. for the period ended February 28, 2021;

2.	Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.	Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 14, 2021

By:

/s/ Timothy Orr

Timothy Orr

President, Secretary and Treasurer

(principal executive officer,

principal accounting officer and

principal financial officer)

EX-32.1 4 gmvp_ex321.htm CERTIFICATION gmvp_ex321.htm

EXHIBIT 32.1

SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER OF GRIDIRON BIONUTRIENTS, INC.

In connection with the accompanying Quarterly Report on Form 10-Q of Gridiron BioNutrients, Inc. for the quarter ended February 28, 2021, the undersigned, Timothy Orr, Secretary and Treasurer of Gridiron BioNutrients, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	such Quarterly Report on Form 10-Q for the quarter ended February 28, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)	the information contained in such Quarterly Report on Form 10-Q for the quarter ended February 28, 2021 fairly presents, in all material respects, the financial condition and results of operations of Gridiron BioNutrients, Inc.

Date: April 14, 2021

By:

/s/ Timothy Orr

President, Secretary and Treasurer

(principal executive officer,

principal accounting officer and

principal financial officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 5 gmvp-20210228.xml XBRL INSTANCE DOCUMENT 0001629205 2020-09-01 2021-02-28 0001629205 us-gaap:SubsequentEventMember gmvp:CalavaryFundManagementLLCMember gmvp:ExchangeAgreementMember gmvp:SeriesBConvertiblePreferredStockMember 2021-04-01 2021-04-09 0001629205 us-gaap:SubsequentEventMember gmvp:CalavaryFundManagementLLCMember gmvp:ExchangeAgreementMember gmvp:SeriesBConvertiblePreferredStockMember 2021-04-09 0001629205 gmvp:NGBLMember gmvp:CollaborationAgreementMember 2020-01-24 0001629205 gmvp:NGBLMember gmvp:CollaborationAgreementMember 2020-01-01 2020-01-24 0001629205 gmvp:NGBLMember gmvp:CollaborationAgreementMember 2021-02-28 0001629205 gmvp:TollProcessingAgreementMember 2019-11-26 2019-12-13 0001629205 gmvp:NonbindingLetterOfIntentMember gmvp:NanoPeakPerformancesLLCMember 2020-01-01 2020-01-31 0001629205 gmvp:NonbindingLetterOfIntentMember gmvp:NanoPeakPerformancesLLCMember 2019-09-01 2020-08-31 0001629205 gmvp:NonbindingLetterOfIntentMember gmvp:NanoPeakPerformancesLLCMember 2019-10-01 2019-10-31 0001629205 gmvp:NonbindingLetterOfIntentMember gmvp:NanoPeakPerformancesLLCMember 2020-02-01 2020-02-29 0001629205 gmvp:IndustrialHempBiomassRawMaterialMember 2019-09-01 2020-08-31 0001629205 gmvp:IndustrialHempBiomassRawMaterialMember 2019-10-24 2019-11-27 0001629205 us-gaap:InvestorMember 2020-01-27 0001629205 us-gaap:InvestorMember 2020-01-01 2020-01-27 0001629205 gmvp:AugustThirtyOneTwentyEighteenMember gmvp:DerivativesMember 2021-02-28 0001629205 gmvp:AugustThirtyOneTwentyEighteenMember gmvp:DerivativesMember 2020-09-01 2021-02-28 0001629205 gmvp:DerivativesLiabilityMember 2021-02-28 0001629205 gmvp:DerivativesLiabilityMember 2020-09-01 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesTwoMember gmvp:DerivativeLiabilitiesMember 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesTwoMember gmvp:DerivativeLiabilitiesMember 2020-09-01 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesOneMember gmvp:DerivativeLiabilitiesMember 2020-09-01 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesOneMember gmvp:DerivativeLiabilitiesMember 2019-08-31 0001629205 gmvp:ConvertiblePromissoryNotesOneMember gmvp:DerivativeLiabilitiesMember 2018-09-01 2019-08-31 0001629205 gmvp:ConvertiblePromissoryNotesTwoMember gmvp:DerivativesLiabilitiesRevaluationMember 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesTwoMember gmvp:DerivativesLiabilitiesRevaluationMember 2020-09-01 2021-02-28 0001629205 gmvp:ConvertibleNotesPayableOneMember gmvp:DerivativesLiabilityRevaluationMember 2021-02-28 0001629205 gmvp:ConvertibleNotesPayableOneMember gmvp:DerivativesLiabilityRevaluationMember 2020-09-01 2021-02-28 0001629205 gmvp:RevaluationOfDerivativeLiabilityMember 2021-02-28 0001629205 gmvp:RevaluationOfDerivativeLiabilityMember 2020-09-01 2021-02-28 0001629205 us-gaap:ConvertibleNotesPayableMember gmvp:DerivativeLiabilityMember 2021-02-28 0001629205 us-gaap:ConvertibleNotesPayableMember gmvp:DerivativeLiabilityMember 2020-09-01 2021-02-28 0001629205 gmvp:DerivativeLiabilitySummaryMember 2019-09-01 2019-11-30 0001629205 gmvp:DerivativeLiabilitySummaryMember 2020-09-01 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesTwoMember 2019-11-25 0001629205 gmvp:ConvertiblePromissoryNotesTwoMember 2019-11-01 2019-11-25 0001629205 gmvp:ConvertiblePromissoryNotesTwoMember 2020-09-01 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesTwoMember 2021-02-28 0001629205 gmvp:MonteCarloSimulationModelMember 2020-09-01 2021-02-28 0001629205 gmvp:MonteCarloSimulationModelMember 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesOneMember 2018-09-01 2019-08-31 0001629205 gmvp:ConvertiblePromissoryNotesOneMember 2019-08-31 0001629205 2019-08-27 0001629205 gmvp:StockOptionsMember 2020-09-01 2021-02-28 0001629205 gmvp:WarrantsMember 2020-09-01 2021-02-28 0001629205 2020-01-01 2020-01-28 0001629205 2020-01-28 0001629205 gmvp:PresidentAndDirectorMember 2020-08-31 0001629205 gmvp:PresidentAndDirectorMember 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesOneMember 2019-08-27 0001629205 gmvp:ConvertiblePromissoryNotesOneMember 2020-08-31 0001629205 gmvp:ConvertiblePromissoryNotesOneMember 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesOneMember 2019-08-01 2019-08-27 0001629205 gmvp:ShortTermDebtsMember 2020-08-31 0001629205 gmvp:ShortTermDebtsMember 2021-02-28 0001629205 gmvp:ShortTermDebtsMember 2017-09-01 2017-09-14 0001629205 gmvp:ShortTermDebtsMember 2017-09-14 0001629205 gmvp:ShortTermDebtOneMember 2018-05-01 2018-05-31 0001629205 gmvp:ShortTermDebtOneMember 2018-05-31 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2019-09-01 2020-02-29 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2020-09-01 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2020-01-01 2020-01-20 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2020-05-15 2020-06-15 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2020-01-20 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2020-04-27 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2020-08-31 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesMember us-gaap:InvestorMember 2020-04-01 2020-04-27 0001629205 gmvp:ConvertiblePromissoryNotesFourMember 2019-11-01 2019-11-25 0001629205 gmvp:ConvertiblePromissoryNotesFourMember 2020-08-31 0001629205 gmvp:ConvertiblePromissoryNotesFourMember 2021-02-28 0001629205 gmvp:ConvertiblePromissoryNotesFourMember 2019-11-25 0001629205 gmvp:NGBLMember 2020-09-01 2021-02-28 0001629205 gmvp:NGBLMember 2020-01-01 2020-01-24 0001629205 gmvp:NGBLMember 2020-01-24 0001629205 gmvp:ParticipationAgreementMember gmvp:LibertasFundingLLCMember gmvp:ConnecticutLimitedLiabilityCompanyMember 2020-08-31 0001629205 gmvp:ParticipationAgreementMember gmvp:LibertasFundingLLCMember gmvp:ConnecticutLimitedLiabilityCompanyMember 2021-02-28 0001629205 gmvp:ParticipationAgreementMember gmvp:LibertasFundingLLCMember gmvp:ConnecticutLimitedLiabilityCompanyMember 2020-04-01 2020-04-27 0001629205 gmvp:LibertasParticipationAgreementMember gmvp:QSIHoldingCompanyMember 2020-04-29 0001629205 gmvp:LibertasParticipationAgreementMember gmvp:QSIHoldingCompanyMember 2020-04-01 2020-04-29 0001629205 gmvp:SeptemberOneTwoThousandTwentyMember 2020-09-01 2021-02-28 0001629205 2019-09-01 2019-11-30 0001629205 gmvp:RawMaterialsMember 2020-08-31 0001629205 gmvp:RawMaterialsMember 2021-02-28 0001629205 gmvp:TFreeDistillateMember 2020-08-31 0001629205 gmvp:TFreeDistillateMember 2021-02-28 0001629205 us-gaap:OtherMachineryAndEquipmentMember 2020-08-31 0001629205 us-gaap:OtherMachineryAndEquipmentMember 2021-02-28 0001629205 us-gaap:ComputerEquipmentMember 2020-08-31 0001629205 us-gaap:ComputerEquipmentMember 2021-02-28 0001629205 us-gaap:VehiclesMember 2020-09-01 2021-02-28 0001629205 gmvp:ComputerAndOtherEquipmentMember 2020-09-01 2021-02-28 0001629205 gmvp:MyCloudzMember gmvp:ReverseMergerMember 2017-10-10 0001629205 gmvp:AccumulatedDeficitMember 2020-12-01 2021-02-28 0001629205 gmvp:CommonStockToBeIssuedMember 2020-12-01 2021-02-28 0001629205 us-gaap:AdditionalPaidInCapitalMember 2020-12-01 2021-02-28 0001629205 us-gaap:CommonStockMember 2020-12-01 2021-02-28 0001629205 us-gaap:PreferredStockMember 2020-12-01 2021-02-28 0001629205 2020-11-30 0001629205 gmvp:AccumulatedDeficitMember 2020-11-30 0001629205 gmvp:CommonStockToBeIssuedMember 2020-11-30 0001629205 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001629205 us-gaap:CommonStockMember 2020-11-30 0001629205 us-gaap:PreferredStockMember 2020-11-30 0001629205 gmvp:AccumulatedDeficitMember 2021-02-28 0001629205 gmvp:CommonStockToBeIssuedMember 2021-02-28 0001629205 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001629205 us-gaap:CommonStockMember 2021-02-28 0001629205 us-gaap:PreferredStockMember 2021-02-28 0001629205 gmvp:AccumulatedDeficitMember 2020-09-01 2021-02-28 0001629205 gmvp:CommonStockToBeIssuedMember 2020-09-01 2021-02-28 0001629205 us-gaap:AdditionalPaidInCapitalMember 2020-09-01 2021-02-28 0001629205 us-gaap:CommonStockMember 2020-09-01 2021-02-28 0001629205 us-gaap:PreferredStockMember 2020-09-01 2021-02-28 0001629205 gmvp:AccumulatedDeficitMember 2020-08-31 0001629205 gmvp:CommonStockToBeIssuedMember 2020-08-31 0001629205 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001629205 us-gaap:CommonStockMember 2020-08-31 0001629205 us-gaap:PreferredStockMember 2020-08-31 0001629205 gmvp:AccumulatedDeficitMember 2019-12-01 2020-02-29 0001629205 gmvp:CommonStockToBeIssuedMember 2019-12-01 2020-02-29 0001629205 us-gaap:AdditionalPaidInCapitalMember 2019-12-01 2020-02-29 0001629205 us-gaap:CommonStockMember 2019-12-01 2020-02-29 0001629205 us-gaap:PreferredStockMember 2019-12-01 2020-02-29 0001629205 2019-11-30 0001629205 gmvp:AccumulatedDeficitMember 2019-11-30 0001629205 gmvp:CommonStockToBeIssuedMember 2019-11-30 0001629205 us-gaap:AdditionalPaidInCapitalMember 2019-11-30 0001629205 us-gaap:CommonStockMember 2019-11-30 0001629205 us-gaap:PreferredStockMember 2019-11-30 0001629205 2020-02-29 0001629205 gmvp:AccumulatedDeficitMember 2020-02-29 0001629205 gmvp:CommonStockToBeIssuedMember 2020-02-29 0001629205 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0001629205 us-gaap:CommonStockMember 2020-02-29 0001629205 us-gaap:PreferredStockMember 2020-02-29 0001629205 gmvp:AccumulatedDeficitMember 2019-09-01 2020-02-29 0001629205 gmvp:CommonStockToBeIssuedMember 2019-09-01 2020-02-29 0001629205 us-gaap:AdditionalPaidInCapitalMember 2019-09-01 2020-02-29 0001629205 us-gaap:CommonStockMember 2019-09-01 2020-02-29 0001629205 us-gaap:PreferredStockMember 2019-09-01 2020-02-29 0001629205 2019-08-31 0001629205 gmvp:AccumulatedDeficitMember 2019-08-31 0001629205 gmvp:CommonStockToBeIssuedMember 2019-08-31 0001629205 us-gaap:AdditionalPaidInCapitalMember 2019-08-31 0001629205 us-gaap:CommonStockMember 2019-08-31 0001629205 us-gaap:PreferredStockMember 2019-08-31 0001629205 2019-09-01 2020-02-29 0001629205 2019-12-01 2020-02-29 0001629205 2020-12-01 2021-02-28 0001629205 2020-08-31 0001629205 2021-02-28 0001629205 2021-04-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure GRIDIRON BIONUTRIENTS, INC. 0001629205 10-Q false --08-31 true false false Yes 2021-02-28 Non-accelerated Filer Q2 2021 188616 true false Yes

25294

17881

36450

37450

6000

13945

61081

132852

128825

202128

6957

2783

1196

2012

1680

9833

6475

138658

208603

522841

443496

61600

73469

881779

1454480

10000

945769

831170

99145

73995

2521134

2886610

8480

188

187

1157252

1157253

-3548396

-3843927

-2382476

-2678007

138658

208603

3960

3144

0.001

25000000

8480000

0.001

200000000

188616

187194

188616

187194

3080

633

1421

1552

1659

-919

156

466

365

1837

15375

33375

30375

58275

10675

27268

22682

45089

30068

-13057

61689

-2848

56274

48052

115111

102353

-56274

-48052

-113452

-103272

40136

40506

76886

43456

-21018

-48743

0 35118 0 37000

-665343

909090

-572701

1055317

34088 167069 114599 184031 0 429800 0 476408

-2087

-4174

-614224

1581583

-434133

1796212

557950

-1629635

320681

-1899484

2.97

-4.18

1.71

-4.58

187937

390016

187563

414695

8480000

439556

8480

439

1077001

160000

-1213559

32361

742 0 1 159999 -160000 0 -253104 0 -253 -79747 0 -80000 0 0 0 0 -25150 -25150 0 0 0 0 -1899484 -1899484

8480000

187194

8480

187

1157253

-3138193

-1972273

8480000

440027

8480

440

1237000

-1495983

-250063

-252833 0 -253 -79747 0 -80000 0 0 0 0 -12575 -12575 0 0 0 0 -1629635 -1629635

8480000

187194

8480

187

1157253

-3843927

0 0 0 0 -25150 -25150 1422 0 1 -1 0 0 0 0 0 0 0 320681 320681

8480000

188616

8480

188

1157252

-3548396

8480000

187194

8480

187

1157253

-4093771

-2927851

0 0 0 0 -12575 -12575 1422 0 1 -1 0 0 0 0 0 0 0 557950 557950

816

1306

476408

-572701

1055317

114599

184031

20399

0 -39500

-4174

1000

-320203

7945

5151

71771

79345

29872

-11869

28514

7413

-421189

80000

0 100000

-180000

625500

7413

24311

18975

43286

25150 25150 0 695000

160000

<div style="TEXT-ALIGN:justify; FONT: 10pt TIMES NEW ROMAN">Gridiron BioNutrients, Inc. (the “Company” or “Gridiron”) was formed under the laws of the state of Nevada on July 20, 2017 to develop and distribute a retail line of health water infused with probiotics and minerals. The Company is currently developing products which contain a proprietary blend of humic and fulvic acid, trace minerals, probiotics, electrolytes, cannabidiol (CBD) within an alkaline of pH10. Gridiron has secured the rights to this proprietary formulation through its CEO, Timothy Orr (Verbal Agreement). Timothy Orr provided the formulation in connection with his receipt of 105,519 shares of common stock from the Company on October 9, 2017. Gridiron has the exclusive right(s) to develop CBD products with this formulation. However, Gridiron is limited to developing only CBD products with this formulation and as such does not have any rights to develop products that do not contain CBD with this formulation. The Company has elected an August 31st year end. On December 22, 2020, the Company filed Articles of Amendment to its Articles of Incorporation, as amended, which were effective on January 8, 2021 (the “Effective Date”), which effected a three hundred eight for one (308:1) reverse stock split of its outstanding common stock. Previously, on December 4, 2020 the Company filed a definitive Information Statement on Schedule 14C with the SEC notifying its stockholders that on December 2, 2020, the holders of a majority of its outstanding shares of common stock and the shares Series A Convertible Preferred Stock who were entitled to consent to the action, voting as a single class, executed a written consent in lieu of a special meeting of stockholders approving a reverse stock split of the Company’s outstanding common stock of not less than 300:1 and not more than 310:1, with the Company’s board of directors having the discretion as to when such reverse stock split would be effected (on or prior to December 2, 2021) and the exact ratio of the reverse stock split to be set at a whole number within the above range as determined by the board of directors in its sole discretion. On December 17, 2020, in accordance with such authority, the board of directors fixed the exact ratio of the reverse stock split. Acquisition and Reverse Merger On October 10, 2017, the Company completed a reverse merger with My Cloudz, Inc. (“My Cloudz”) pursuant to which the Company merged into My Cloudz on October 10, 2017. Under the terms of the merger, the Company shareholders received 227,273 common shares of My Cloudz common stock such that the Company shareholders received approximately 57% of the total common shares issued and outstanding following the merger. Due to the nominal assets and limited operations of My Cloudz prior to the merger, the transaction was accorded reverse recapitalization accounting treatment under the provision of Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 805 whereby the Company became the accounting acquirer (legal acquiree) and My Cloudz was treated as the accounting acquiree (legal acquirer). The historical financial records of the Company are those of the accounting acquirer (GridIron) adjusted to reflect the legal capital of the accounting acquiree (My Cloudz). As the transaction was treated as a recapitalization, no intangibles, including goodwill, were recognized. Concurrent with the effective date of the reverse recapitalization transaction, the Company adopted the fiscal year end of the accounting acquirer of August 31. At the date of acquisition, My Cloudz had $3,972 of cash, $1,105 of accounts payable and a related party payable of $75,907. Book values for all assets acquired and liabilities assumed equaled fair values as of the date of acquisition.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Basis of Presentation   The Company’s unaudited consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern, which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business, and in accordance with the instructions for Form 10-Q and Article 10 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended. Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.   In the opinion of management, the consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.   The results for the three and six-months ended February 28, 2021 are not necessarily indicative of the results of operations for the full year. These unaudited financial statements and related footnotes should be read in conjunction with the amended consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2020 filed with the Securities and Exchange Commission on December 15, 2020.   Reclassifications   Certain prior year amounts have been reclassified for comparative purposes to conform to the current-year financial statement presentation. These reclassifications had no effect on previously reported results.   Use of Estimates   The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. Estimates are used when accounting for fair value calculations related to embedded conversion features of outstanding convertible notes payable.   Cash   For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes. The Company had $25,294 and $17,881 of cash as of February 28, 2021 and August 31, 2020, respectively.   Revenue recognition   The Company recognizes revenue under ASU No. 2014-09, ”Revenue from Contracts with Customers (Topic 606),” (“ASC 606”). The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer.   Revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration that an entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.   Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery.   Fair Value of Financial Instruments   Fair value of certain of the Company’s financial instruments including cash, prepaid expenses, accounts payable, accrued expenses, notes payable, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.   Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.   Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:   Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.   Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and   Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.   Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.   As discussed in Note 9 – Derivative Liability, the Company valued its derivative liability using Level 3 inputs as of February 28, 2021 and August 31, 2020. The Company did not identify any additional assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with ASC 825-10 as of February 28, 2021 and August 31, 2020.   Derivative Liabilities   The Company generally does not use derivative financial instruments to hedge exposures to cash flow or market risks. However, certain other financial instruments, such as warrants and embedded conversion features on the convertible debt, are classified as derivative liabilities due to protection provisions within the agreements. Convertible notes payable are initially recorded at fair value using the Monte Carlo model and subsequently adjusted to fair value at the close of each reporting period. The preferred stock warrants are initially recorded at fair value using the Black Scholes model and subsequently adjusted to fair value at the close of each reporting period. The Company accounts for derivative instruments and debt instruments in accordance with the interpretive guidance of ASC 815, ASU 2017-11, and associated pronouncements related to the classification and measurement of warrants and instruments with conversion features.   Income Taxes   Income taxes are accounted for under the assets and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Use of net operating loss carry forwards for income tax purposes may be limited by Internal Revenue Code section 382 if a change of ownership occurs.   Principals of Consolidation   The consolidated financial statements represent the results of Gridiron BioNutrients, Inc, its wholly owned subsidiary, Gridiron Ventures and the assets, processes, and results therefrom. All intercompany transactions and balances have been eliminated. All financial information has been prepared in conformity with accounting principles generally accepted in the United States of America.   Property and Equipment   Property and equipment are carried at cost. Expenditures for maintenance and repairs are expensed in the period incurred. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period.   Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets and the modified accelerated cost recovery system for federal income tax purposes. The estimated useful lives of depreciable assets are:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:78%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"> Estimated Useful Lives</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:78%;vertical-align:bottom;"> Computer and other equipment</td> <td style="width:1%;">  </td> <td style="width:8%;"> 3 years</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:78%;vertical-align:bottom;"> Vehicle</td> <td style="width:1%;">  </td> <td style="width:8%;"> 5 years</td> <td style="width:1%;">  </td></tr></table>   The Company’s property and equipment consisted of the following as of February 28, 2021 and August 31, 2020:   <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td>  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> February 28, 2021</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> August 31, 2020</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Computer Equipment</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,569</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,569</td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Other</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,587</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,587</td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Accumulated depreciation</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,960</td> <td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,144</td> <td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Net book value</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,196</td> <td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,012</td> <td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;">  </td></tr></table>   Depreciation expense was $387 and $653 for three months ended February 28, 2021 and February 29, 2020, respectively, and $816 and $1,307 for six months ended February 28, 2021 and February 29, 2020, respectively.   Inventories   Inventories consist of raw materials and T-free distillate and are stated at the lower of cost or net realizable value using the first‑in, first‑out method. The Company periodically assesses the recoverability of its inventory and reduces the carrying value of the inventory when items are determined to be obsolete, defective or in excess of forecasted sales requirements. Inventory write‑downs for excess, defective and obsolete inventory are recorded as impairment expense in the accompanying statement of operations. The Company wrote-off $-0- and $35,118 of obsolete inventory or inventory below market value for the three months ended February 28, 2021 and February 29, 2020, respectively, and $-0- and $37,000 for the six months ended February 28, 2021 and February 29, 2020, respectively.   A summary of the Company’s inventory as of February 28, 2021 and August 31, 2020 are as follows:   <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"> Type</td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> February 28, 2021</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> August 31, 2020</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Raw Materials</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">450</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">450</td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> T-free Distillate</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">36,000</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,000</td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td>  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;">  </td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Total Inventory</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">36,450</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,450</td> <td style="width:1%;white-space: nowrap;">  </td></tr></table>   Basic Income (Loss) Per Share   Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.   The preferred conversion and warrants would account for approximately 167,000 additional shares, the convertible debt would account for approximately 1,000,000 additional shares along with the 188,616 outstanding shares at February 28, 2021. The Company calculates diluted earnings per share by dividing the Company’s net income available to common shareholders less preferred dividends by the diluted weighted average number of shares outstanding during the period. The Company’s convertible notes and warrants are excluded from the computation of diluted earnings per share as they are anti-dilutive due to the Company’s operating losses for the six months ended February 28, 2021 and February 29, 2020.   Dividends   As discussed in Note 7 – Stockholders Equity (Deficit), during the year ended August 31, 2018, the Company issued preferred stock which accrues dividends at a rate of 5% annually. There was $99,145 and $73,995 of dividends payable at February 28, 2021 and August 31, 2020, respectively. The dividends have not been declared and are accrued in the accompanying consolidated balance sheets as a result of a contractual obligation in the Company’s preferred stock offering.   Advertising Costs   The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising costs totaling $156 and $466 during the three months ended February 28, 2021 and February 29, 2020, respectively, and $365 and $1,837 during the six months ended February 28, 2021 and February 29, 2020, respectively.   Stock-Based Compensation   The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718. The Company issues restricted stock to employees and consultants for their services. Cost for these transactions are measured at the fair value of the equity instruments issued at the date of grant. These shares are considered fully vested and the fair market value is recognized as expense in the period granted. The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services. For agreements requiring future services, the consulting expense is to be recognized ratably over the requisite service period.   There was $-0- stock-based compensation during the three and six months ended February 28, 2021 and February 29, 2020.   Related Parties   The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.   Pursuant to Section 850-10-20 the related parties include (a) affiliates of the Company; (b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; (d) principal owners of the Company; (e) management of the Company; (f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.   The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a) the nature of the relationship(s) involved; (b) description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.   Recently Issued Accounting Standards   In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, “Disclosure Update and Simplification,” amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. This analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule was effective as of November 5, 2018. The adoption of this final rule did not have a material impact on the financial statements.   In February 2018, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-02, Income Statement Reporting, Comprehensive Income (Topic 220). Effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The Company has adopted 2018-02 and determined there was no material impact on the financial statements.   In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, as part of its Simplification Initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The guidance is effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effect ASU 2019-12 will have on the consolidated financial statements and related disclosures.   In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluation the impact this ASU will have on its consolidated financial statements.   Management believes recently issued accounting pronouncements will have no impact on the financial statements of the Company.   Accounts Receivable   Accounts receivable balances are established for amounts owed to the Company from its customers from the sale of products. The Company closely monitors the collectability of outstanding accounts receivable and provide an allowance for doubtful accounts based on estimated collections of outstanding amounts. The Company evaluated the accounts receivable and determined no collection loss reserve was necessary. There were $-0- outstanding accounts receivable as of February 28, 2021 and August 31, 2020.   Trademark   Trademark costs are capitalized as incurred to the extent the Company expects the costs incurred to result in a trademark being awarded. The trademarks are deemed to have an indefinite life and are reviewed for impairment loss considerations annually. As of February 28, 2021 and August 31, 2020, the Company had trademarks totaling $1,680.</div>

<div style="TEXT-ALIGN:justify; FONT: 10pt TIMES NEW ROMAN">The Company’s financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company had limited revenue and net income of $320,681 for the six months ended February 28, 2021. The net income includes a non-cash $572,701 gain from change in fair value of derivative liability. The Company has working capital deficit of $2,392,309 and an accumulated deficit of $3,548,396 as of February 28, 2021. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. The ability of the Company to fully commence its operations is dependent upon, among other things, obtaining additional financing to continue operations, and execution of its business plan. In response to these concerns, management plans to fund operations through additional debt and equity financing. Debt instruments may be convertible or non-convertible and will vary based on the Company’s needs and financing options available at such times. There can be no assurance that management’s plan will be successful.</div>

<div style="TEXT-ALIGN:justify; FONT: 10pt TIMES NEW ROMAN">On January 24, 2020, the Company received a promissory note from a supplier, Notis Global, Inc. (“NGBL”). The $112,500 note was issued with an original issue discount of $12,500 or 12.5%. NGBL will repay the promissory note with 12.5% of its sales of derivative products of hemp planted and harvested in 2020. In addition, once the promissory note has been repaid, the Company shall be paid an aggregate of 3.75% of the 2020 derivative products revenues sold by the supplier. The original issue discount is amortized through the term of the note. At August 31, 2020, the Company evaluated the promissory noted under ASU 2016-16, “Financial Instruments – Credit Losses, (Topic 326)” and determined the entire balance was impaired. The Company reported an $100,000 impairment charge at August 31, 2020. On April 27, 2020, the Company entered into a Participation Agreement, effective April 27, 2020, with Libertas Funding, LLC, a Connecticut Limited Liability Company (“Libertas”), pursuant to which Libertas offered and the Company accepted to participate with Future Receivables in Purchase Agreement(s) with qualifying merchants, specifically QSI Holding Company, a Delaware Corporation (“QSI”). The Company’s participation buy-in amount was $200,000 with a participation purchase of $264,000 that is estimated to result in weekly payments to the Company for a minimum period of six months or until the full participation purchase amount has been paid. The $200,000 buy-in was recorded as a Note receivable on the accompanying consolidated balance sheets. On September 1, 2020, Libertas renegotiated this agreement and the Company will receive weekly payments for $4,921 and extended the term to 38 weeks. The previous weekly payment was $6,984. The unpaid balance was $61,081 and $132,852 at February 28, 2021 and August 31, 2020, respectively. In addition, on April 29, 2020, under the Libertas Participation Agreement, the Company received 45,053 Warrants of QSI Holding Company, a private company, (“QSI Warrants”) to purchase common stock priced at $3.111 per share for common stock par value $0.00001 expiring the 7th anniversary after the issue date. Upon issuance, the Company valued the warrants using the Black Scholes model yielding a total value of $58,443. The Company used the following assumptions upon measurement: QSI Holding Company value per common share of $3.4520, a life of 7 years, an exercise price of $3.111, a risk-free rate of 0.56% and volatility of 32%. In addition, the Company recorded a discount of $58,443 and will record income over the 7-year life of the warrants. The warrants are recorded as an equity investment in the accompanying consolidated balance sheets for $6,957 and $2,783 at February 28, 2021 and August 31, 2020, respectively. The Company recorded other income of $2,087 and $-0-, respectively for the three months ended February 28, 2021 and February 29, 2020, respectively, and $4,174 and $-0-, respectively for the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying statement of operations.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Short-Term Notes Payable   On September 14, 2017, the Company issued a $10,000 promissory note to a limited liability company. The loan bears interest at 5% and has a maturity date of September 15, 2018. The unpaid balance including accrued interest was $11,730 and $11,482 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note.   On May 31, 2018, the Company issued a $39,500 promissory note to a company. The loan bears interest at 0% and has a maturity date of November 30, 2018. During March 2020, it was discovered the promissory note was fully paid-off on August 6, 2018 and inadvertently recorded as an operating expense for the year ended August 31, 2018. At February 29, 2020, the Company wrote-off the promissory note to operating expense. The unpaid balance was $-0- at February 28, 2021 and August 31, 2020.   Convertible Notes Payable   On August 27, 2019, the Company signed a convertible promissory note with an investor. The $30,000 note was issued with an original issue discount of $3,000 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 25% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on February 27, 2020. The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance. After February 27, 2020, the payment premium increases to 125% of the principal and interest outstanding and if in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. The unpaid balance including accrued interest was $49,548 and $46,870 at February 28, 2021 and August 31, 2020, respectively. On March 3, 2020, the Company was granted an extension of payment terms to August 1, 2020. The five-month extension does not modify any terms in the convertible promissory note. The Company is in default with the repayment terms of the note.   On November 25, 2019, the Company signed a convertible promissory note with an investor. The $140,000 note was issued with an original issue discount of $14,000 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on May 25, 2020. The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance. If in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. On May 27, 2020, the Company was granted an extension of payment terms to November 30, 2020. The six-month extension does not modify any terms in the convertible promissory note. The unpaid balance including accrued interest was $225,073 and $212,577 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note.        On January 27, 2020, the Company signed a convertible promissory note with an investor. The $555,000 note was issued with an original issue discount of $55,500 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on July 27, 2020. The note has a prepayment penalty of 115% of the principal and interest outstanding if repaid more than 30 days after note issuance. If in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. The unpaid balance including accrued interest was $875,014 and $825,475 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note.   On April 27, 2020, the Company signed a convertible promissory note with an investor. The $259,615 note was issued with an original issue discount of $57,115 and bears interest at -0-% per year. The Company recorded the self-amortizing convertible promissory note using the effective interest rate method to calculate the loan payable at $202,500 and accrued interest at $57,115. The note requires nine equal payments due starting June 15, 2020 for $28,846. In the event the Company fails to make the $28,846 installment payment by the 15th day of each designated month and/or fails to cure any missed installment payment within five (5) calendars days following the due date, or the Company defaults, the defaulted amount owed shall be 130% of the total outstanding balance owed by the Company. The default interest rate for missing an installment payment shall be 18% and the conversion into common stock shall be at a price of $0.02 per common stock. The note principal and interest are convertible into shares of common stock at the lower of $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matures on February 21, 2021. The Company made the first payment on June 15, 2020 for $28,846 and a partial payment of $10,000 on July 15, 2020. The original issue discount is amortized through the term of the note. The unpaid principal and interest balance was $299,590 and $287,665 February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note.   The conversion features meet the definition of a derivative liability instrument because the conversion rate is variable and therefore does not meet the “fixed-for-fixed” criteria outlined in ASC 815-40-15. As a result, the conversion features of the notes are recorded as a derivative liability at fair value and marked-to-market each period with the changes in fair value each period charged or credited to other income (expense). See Note 9 - Derivative Liability, for a further discussion.   At February 28, 2021 and August 31, 2020, the outstanding principal balances of the convertible notes payable, net of debt discount was $945,769 and $831,170, respectively. The Company recorded interest accretion on the debt discount of $34,088 and $167,069 for the three months ended February 28, 2021 and February 29, 2020, respectively, and $114,599 and $184,031 for the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying consolidated statements of operations.</div>

<div style="TEXT-ALIGN:justify; FONT: 10pt TIMES NEW ROMAN">As of February 28, 2021, and August 31, 2020, the Company owed $61,600 and $73,469, respectively to its President and Director. The balance due is recorded in related party payable in the accompanying consolidated balance sheets.</div>

<div style="TEXT-ALIGN:justify; FONT: 10pt TIMES NEW ROMAN">Preferred Stock There were 8,480,000 preferred shares issued and outstanding as of February 28, 2021 and August 31, 2020. Common Stock On January 8, 2021, a 308-to-1 reverse stock split was declared effective. In accordance with the terms of all such instruments, the conversion ratio of the Company’s outstanding Series A Convertible Preferred Stock and its various convertible promissory notes, together with the exercise price of its outstanding warrants, were proportionally adjusted to give effect to the reverse stock split. The Company is authorized to issue up to 200,000,000 shares of $0.001 par value common stock. On, January 28, 2020, the Company entered into an agreement to repurchase 252,833 restricted shares of the Company’s common stock from an investor. The Company paid $80,000 or $0.3164 per share and immediately retired the shares. There were 188,616 common shares issued and outstanding as of February 28, 2021 and August 31, 2020.</div>

<div style="TEXT-ALIGN:justify; FONT: 10pt TIMES NEW ROMAN">The Company could become a party to various legal actions arising in the ordinary course of business. Matters that are probable of unfavorable outcomes to the Company and which can be reasonably estimated are accrued. Such accruals are based on information known about the matters, the Company’s estimates of the outcomes of such matters and its experience in contesting, litigating and settling similar matters. As of the date of this report, there are no pending legal proceedings to which the Company is a party or of which any of their property is the subject, nor are there any such proceedings known to be contemplated by governmental authorities.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Preferred Stock Warrants   During the year ended August 31, 2018, the Company issued a total of 27,532 warrants to purchase common stock as part of its preferred stock offering. The warrants are exercisable for a period of three years at $50.82 per share. Additionally, the warrant holder is entitled to a cashless exercise after nine months from issuance in which the holder is entitled to receive a number of shares equal to: [A] the number of outstanding warrant shares under the original issuance multiplied by [B] the greater of the trailing five day volume weighted average price less [A] the number of outstanding warrant shares under the original issuance multiplied by [C] the exercise price of the warrant under the original issuance divided by [D] the lesser of the arithmetic average of the volume weighted average price during the five trailing trading days or the volume weighted average price for the trading day immediately prior to the cashless exercise election. For clarity, the resulting formula is [(A x B) – (A x C)] / D.   The Company analyzed the conversion features of the cashless exercise feature in the warrants issued for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded features should be classified as a derivative liability because the exercise price of these warrants are subject to a variable rate. The Company has determined that warrants are not considered to be solely indexed to the Company’s own stock and is therefore not afforded equity treatment. In accordance with ASC 815, the Company has recorded a derivative liability.   Upon issuance, the Company valued the derivative using a Black-Scholes model yielding a total value of $674,012 which was expensed during the year ended August 31, 2018. The Company used the following assumptions upon initial measurement: value per common share of $27.72, a remaining life of 3.0 years, an exercise price of $50.82, a risk-free rate of 2.77% and volatility of 195%.   The Company revalued the derivative liability as of February 28, 2021 and recorded income of $7,735 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon the measurement: value per common share of $2.25, a remaining life of .42 years, an exercise price of $50.82, a risk-free rate of 0.05% and volatility of 265%.   The following table summarizes all stock warrant activity for the six months ended February 28, 2021:   <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td>  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> Warrants</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> Weighted- Average Exercise Price Per Share</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Outstanding, August 31, 2020</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">27,532</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50.82</td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Granted</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Exercised</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Forfeited</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Expired</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Outstanding, February 28, 2021</td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">27,532</td> <td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">50.82</td> <td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;">  </td></tr></table>   The following table discloses information regarding outstanding and exercisable warrants at February 28, 2021:   <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="2">  </td> <td style="white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="10"> Outstanding</td> <td style="white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="6"> Exercisable</td> <td style="white-space: nowrap;">  </td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"> Exercise Prices</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> Number of Warrant Shares</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> Weighted Average Exercise Price</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> Weighted Average Remaining Life (Years)</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> Number of Warrant Shares</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td> <td style="white-space: nowrap;">  </td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> Weighted Average Exercise Price</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td style="BORDER-BOTTOM: 1px solid;width:23%;">50.82</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;text-align:right;">27,532</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;text-align:right;">50.82</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;text-align:right;">0.66</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;">  </td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;text-align:right;">27,532</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">  </td> <td style="width:1%;white-space: nowrap;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;text-align:right;">50.82</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">  </td></tr></table>   Convertible Notes Payable   As discussed in Note 5 – Notes Payable, the Company signed various convertible promissory note with an investor as follows:   On August 27, 2019, the Company signed a $30,000 convertible promissory note with an investor. The note principal and interest are convertible into shares of common stock at a 25% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.   The Company analyzed the conversion feature and determine it meets the definition of a derivative liability instrument because the conversion rate is variable and therefore does not meet the “fixed-for-fixed” criteria outlined in ASC 815-40-15. As a result, the conversion features of the notes are recorded as a derivative liability at fair value and marked-to-market each period with the changes in fair value each period charged or credited to other income (expense).   Upon issuance, the Company valued the derivative using a Monte Carlo simulation model yielding a total value of $50,277 which was recorded as a derivative liability during the year ended August 31, 2019. The Company used the following assumptions upon initial measurement: value per common share of $2.74, a remaining life of 6 months, an exercise price of $1.30, a risk-free rate of 1.98% and volatility of 287%. In addition, the Company calculated the derivative discount as the difference between the conversion price and the fair market value of the Company’s common stock on the date of issuance. The Company recorded an original issue discount of $3,000 and a derivative discount of $27,000 which aggregated a total discount of $30,000 and was recorded as a discount in the accompanying consolidated balance sheet. On the date of issuance, a net loss of $23,277 was recorded in the accompanying statement of operations.   The Company revalued the derivative liability as of February 28, 2021 and recorded expense of $19,747 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 1 month, an exercise price of $1.66, a risk-free rate of .04% and volatility of 162%.   On November 25, 2019, the Company signed a $140,000 convertible promissory note with an investor. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.   The Company analyzed the conversion feature and determine it meets the definition of a derivative liability instrument because the conversion rate is variable and therefore does not meet the “fixed-for-fixed” criteria outlined in ASC 815-40-15. As a result, the conversion features of the notes are recorded as a derivative liability at fair value and marked-to-market each period with the changes in fair value each period charged or credited to other income (expense).   Upon issuance, the Company valued the derivative using a Monte Carlo simulation model yielding a total value of $172,608 which was recorded as a derivative liability during the three months ended November 30, 2019. The Company used the following assumptions upon initial measurement: value per common share of $1.54, a remaining life of 6 months, an exercise price of $0.93, a risk-free rate of 1.61% and volatility of 275%. In addition, the Company calculated the derivative discount as the difference between the conversion price and the fair market value of the Company’s common stock on the date of issuance. The Company recorded an original issue discount of $14,000 and a derivative discount of $126,000 which aggregated a total discount of $140,000 and was recorded as a discount in the accompanying consolidated balance sheet. On the date of issuance, a net loss of $46,608 was recorded in the accompanying statement of operations.   The Company revalued the derivative liability as of February 28, 2021 and recorded expense of $98,879 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 1 month, an exercise price of $1.44, a risk-free rate of .04% and volatility of 162%.   On January 27, 2020, the Company signed a $555,000 convertible promissory note with an investor. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.   The Company analyzed the conversion feature and determine it meets the definition of a derivative liability instrument because the conversion rate is variable and therefore does not meet the “fixed-for-fixed” criteria outlined in ASC 815-40-15. As a result, the conversion features of the notes are recorded as a derivative liability at fair value and marked-to-market each period with the changes in fair value each period charged or credited to other income (expense).   Upon issuance, the Company valued the derivative using a Monte Carlo simulation model yielding a total value of $929,300 which was recorded as a derivative liability during the three months ended February 29, 2020. The Company used the following assumptions upon initial measurement: value per common share of $6.65, a remaining life of 6 months, an exercise price of $3.13, a risk-free rate of 1.57% and volatility of 281%. In addition, the Company calculated the derivative discount as the difference between the conversion price and the fair market value of the Company’s common stock on the date of issuance. The Company recorded an original issue discount of $55,500 and a derivative discount of $499,500 which aggregated a total discount of $555,000 and was recorded as a discount in the accompanying consolidated balance sheet. On the date of issuance, a net loss of $429,800 was recorded in the accompanying statement of operations.   The Company revalued the derivative liability as of February 28, 2021 and recorded expense of $383,074 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 1 month, an exercise price of $1.44, a risk-free rate of 0.04% and volatility of 162%.   On April 27, 2020, the Company signed a $259,615 convertible promissory note with an investor. The note principal and interest are convertible into shares of common stock at $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.   The Company analyzed the conversion feature and determine it meets the definition of a derivative liability instrument because the conversion rate is variable and therefore does not meet the “fixed-for-fixed” criteria outlined in ASC 815-40-15. As a result, the conversion features of the notes are recorded as a derivative liability at fair value and marked-to-market each period with the changes in fair value each period charged or credited to other income (expense).   Upon issuance, the Company valued the derivative using a Monte Carlo simulation model yielding a total value of $587,772 which was recorded as a derivative liability during the three months ended May 31, 2020. The Company used the following assumptions upon initial measurement: value per common share of $3.17, a remaining life of 9 months, an exercise price of $1.28, a risk-free rate of 0.17% and volatility of 304%. In addition, the Company calculated the derivative discount as the difference between the conversion price and the fair market value of the Company’s common stock on the date of issuance. The Company recorded an original issue discount of $57,115 and a derivative discount of $202,500 which aggregated a total discount of $259,615 and was recorded as a discount in the accompanying consolidated balance sheet. On the date of issuance, a net loss of $385,272 was recorded in the accompanying statement of operations.   The Company revalued the derivative liability as of February 28, 2021 and recorded expense of $155,909 on the change in fair value of derivative liabilities for the three months then ended. The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 3 months, an exercise price of $1.44, a risk-free rate of 0.04% and volatility of 162%.   Derivative Liability Summary   As of February 28, 2021 and August 31, 2020, the Company had derivative liabilities totaling $881,779 and $1,454,480, respectively, in the accompanying consolidated balance sheet, and (gain) loss on change in fair value of the derivative liability of ($665,343) and $909,090 for the three months ended February 28, 2021 and February 29, 2020, respectively, and ($572,701) and $1,055,317 for the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying consolidated statement of operations. In addition, the Company amortized $34,088 and $167,069 to interest accretion during the three months ended February 28, 2021 and February 29, 2020, respectively, and $114,599 and $184,031 to interest accretion during the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying consolidated statement of operations for the derivative convertible notes payable.</div>

<div style="TEXT-ALIGN:justify; FONT: 10pt TIMES NEW ROMAN">On September 4, 2019, the Company signed an initial non-binding letter of intent with NanoPeak Performances, LLC with a subsequent addendum for the sale of the majority of its existing inventory as well as the exclusive license to Gridiron intellectual property and other intangible assets. During October 2019, NanoPeak Performances paid a $25,000 non-refundable deposit on the transaction. The Company recorded the deposit in accrued expenses in accompanying consolidated balance sheet. On February 29, 2020, the Company determined the non-binding letter of intent terminated and wrote-off the $25,000 non-refundable deposit other income. In November 2019, the Company made a strategic decision to expand into the cannabinoids (CBD) oil extraction business and on or about November 27, 2019, the Company signed a Supply Agreement with Notis Global, Inc. (“NGBL”), a grower to purchase 10,000 pounds of industrial hemp (biomass) and was processed into crude during the three months ended February 29, 2020. During November 2019, the Company paid $100,000 to the supplier and recorded the purchase in inventory in the accompanying consolidated balance sheet. During January 2020, the Company purchased an additional 30,000 pounds of industrial hemp (biomass) for $5 a pound or $150,000 under the agreement. On August 31, 2020, the Company wrote-down $115,000 of its recently purchased industrial hemp (biomass) raw material to fair market value of $35,000. On December 13, 2019, the Company signed a Toll Processing Agreement with a corporation to process industrial hemp (biomass) into the CBD product. The contract is valued at $100,000. During the year ending August 31, 2020, the Company spent $72,500 to fulfill the contract. On January 24, 2020, the Company signed a Collaboration Agreement with a supplier, Notis Global, Inc. (“NGBL”), to explore and consider potential business opportunities for the parties within various segments of the hemp CBD supply chain including cultivation, extraction and purification and retail products. As consideration for the services to be provided by the Company, NGBL shall issue to the Company 2.5 billion shares of NGBL restricted common stock. Either party may terminate this agreement at any time upon 10 business days’ written notice. The equity investment is valued at $250,000 or 20% ownership of NGBL, however, NGBL is not current with their filing with the Securities and Exchange Commission and do not have the authorized shares to fulfill the agreement. The Company evaluated the shares of NGBL and determined there was $-0- value at February 28, 2021.</div>

<div style="TEXT-ALIGN:justify; FONT: 10pt TIMES NEW ROMAN">On April 9, 2021 Company entered into an Exchange Agreement with Calvary Fund Management, LLC (“Calvary”) pursuant to which it agreed to issue Calvary 2,694,514 shares of its newly designated Series B Convertible Preferred Stock (the “Series B Preferred”) in exchange (the “Exchange”) for (i) 8,480,000 shares of its Series A Convertible Preferred Stock (the “Series A Preferred”), (ii) outstanding common stock purchase warrants (the “Warrants”), and (iii) all principal and accrued interest due under outstanding convertible promissory notes (the “Convertible Notes”, and together with the Series A Preferred and the Warrants, the “Calvary Securities”). The closing of the Exchange (the “Closing”) will occur following the satisfaction or waiver of the conditions set forth in the Exchange Agreement. On the Closing date, subject to the terms and conditions of the Exchange Agreement, the Company will issue the Series B Preferred to Calvary in exchange for the Calvary Securities (which will be cancelled and retired) in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on exemptions provided pursuant to Section 3(a)(9) of the Securities Act. The Series B Preferred Designations designated 2,694,514 shares of the Company’s blank check preferred stock as Series B Preferred Stock. In addition to rights granted to holders of Series B Preferred Stock under the Nevada Revised Statues, each holder will be entitled to the whole number of votes equal to the number of shares of common stock into which such holder’s Series B Preferred Stock would be convertible on the record date for the vote or consent of stockholders, and shall otherwise have voting rights and powers equal to the voting rights and powers of the common stock. Once issued, the shares of Series B Preferred Stock are transferrable by the holder in the holder’s sole option without the consent of the Company, subject to compliance with Section 5 of the Securities Act. The Series B Preferred Stock will rank senior to all other classes of the Company’s capital stock and has a stated value of $1.30 per share (the “Stated Value”). Subject only to the liquidation rights of the holders of Series B Preferred Stock that is then currently issued and outstanding, upon the liquidation, dissolution or winding up of the business of the Company, whether voluntary or involuntary, the Series B Preferred Stock is entitled to receive an amount per share equal to the Stated Value and then receive a pro-rata portion of the remaining assets available for distribution to the holders of common stock on an as-converted to common stock basis.  From and after the Closing date, cumulative dividends on each share of Series B Preferred Stock will accrue, on a quarterly basis in arrears, at the rate of 10% per annum on the Stated Value, plus all dividends, whether declared or not, on such share of Series B Preferred Stock (the “Additional Amount”) thereon. All accrued dividends on each share of Series B Preferred Stock are to be paid upon conversion of the Series B Preferred Stock for which the applicable dividend is due. At the option of the Company dividends may be paid in cash or shares of common stock. Each holder of Series B Preferred Stock will also be entitled to receive dividends or distributions on each share of Series B Preferred Stock on an “as converted” into common stock basis when and if dividends are declared on the common stock by the Company’s Board of Directors. Dividends may be paid in cash or property, as determined by the Board of Directors. Subject to the beneficial ownership limitations described below, at any time after the Closing date, each share of Series B Preferred Stock will be convertible at the holder’s option into validly issued, fully paid and non-assessable shares of common stock at a conversion rate (the “Conversion Rate”) determined by dividing the Conversion Amount of such share of Series B Preferred Stock by the conversion price, which is (i) $1.30 or (ii) 75% of the price paid per share by investors in any subsequent offering of the Company’s common stock or common stock equivalents, subject to adjustment as provided herein, subject to adjustment as set forth below (the “Conversion Price”). The Conversion Amount is defined as the Stated Value plus the Additional Amount and any accrued and unpaid late charges with respect to such Stated Value and Additional Amount as of such date of determination. In addition, the shares of Series B Preferred Stock will be convertible at the holder’s option at the Conversion Price any time during the period commencing on the date of the occurrence of a Triggering Event (as defined in the Series B Preferred Designations). A holder of Series B Preferred Stock will not be able to convert the shares into shares of common stock to the extent such conversion or exercise would cause the holder, together with its affiliates, to beneficially own a number of shares of common stock which would exceed 4.99% of the Company’s then outstanding shares of our common stock following such exercise or conversion, subject to a waiver by the holder upon 61 days’ prior notice to the Company. The Conversion Price and the number of shares of common stock issuable upon conversion of the Series B Preferred Stock will be subject to pro-rata adjustment for stock splits, dividends and similar corporate events. In addition, if on or after April 9, 2021, the execution date of the Exchange Agreement, the Company issues or sells, or is deemed to have issued or sold, any shares of common stock, excluding certain specified excluded securities for a consideration per share (the “New Issuance Price”) less than a price equal to the Conversion Price in effect immediately prior to such issue or sale or deemed issuance or sale, then, immediately after such dilutive issuance, the Conversion Price then in effect shall be reduced to the New Issuance Price. The Series B Preferred Designations or any provision hereof (other than the beneficial ownership limitation set forth above) may be modified or amended or the provisions hereof waived with the written consent of the Company and either (i) the holders of a majority of the Series B Preferred Stock then currently outstanding, which must include Cavalry as long as Cavalry (or any of its affiliates) owns at least 5% of the Series B Preferred Stock issued pursuant to the Exchange Agreement, or (ii) Cavalry as long as Cavalry (or any of its affiliates) owns at least 5% of the Series B Preferred Stock issued pursuant to the Exchange Agreement. The Company has evaluated all other events occurring subsequently to these financial statements through April 14, 2021 and determined there were no other items to disclose.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company’s unaudited consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern, which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business, and in accordance with the instructions for Form 10-Q and Article 10 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended. Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.   In the opinion of management, the consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.   The results for the three and six-months ended February 28, 2021 are not necessarily indicative of the results of operations for the full year. These unaudited financial statements and related footnotes should be read in conjunction with the amended consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2020 filed with the Securities and Exchange Commission on December 15, 2020.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Certain prior year amounts have been reclassified for comparative purposes to conform to the current-year financial statement presentation. These reclassifications had no effect on previously reported results.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. Estimates are used when accounting for fair value calculations related to embedded conversion features of outstanding convertible notes payable.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes. The Company had $25,294 and $17,881 of cash as of February 28, 2021 and August 31, 2020, respectively.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company recognizes revenue under ASU No. 2014-09, ”Revenue from Contracts with Customers (Topic 606),” (“ASC 606”). The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer.   Revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration that an entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.   Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Fair value of certain of the Company’s financial instruments including cash, prepaid expenses, accounts payable, accrued expenses, notes payable, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments.   Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk.   Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:   Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.   Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and   Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.   Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income.   As discussed in Note 9 – Derivative Liability, the Company valued its derivative liability using Level 3 inputs as of February 28, 2021 and August 31, 2020. The Company did not identify any additional assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with ASC 825-10 as of February 28, 2021 and August 31, 2020.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company generally does not use derivative financial instruments to hedge exposures to cash flow or market risks. However, certain other financial instruments, such as warrants and embedded conversion features on the convertible debt, are classified as derivative liabilities due to protection provisions within the agreements. Convertible notes payable are initially recorded at fair value using the Monte Carlo model and subsequently adjusted to fair value at the close of each reporting period. The preferred stock warrants are initially recorded at fair value using the Black Scholes model and subsequently adjusted to fair value at the close of each reporting period. The Company accounts for derivative instruments and debt instruments in accordance with the interpretive guidance of ASC 815, ASU 2017-11, and associated pronouncements related to the classification and measurement of warrants and instruments with conversion features.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Income taxes are accounted for under the assets and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Use of net operating loss carry forwards for income tax purposes may be limited by Internal Revenue Code section 382 if a change of ownership occurs.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The consolidated financial statements represent the results of Gridiron BioNutrients, Inc, its wholly owned subsidiary, Gridiron Ventures and the assets, processes, and results therefrom. All intercompany transactions and balances have been eliminated. All financial information has been prepared in conformity with accounting principles generally accepted in the United States of America.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Property and equipment are carried at cost. Expenditures for maintenance and repairs are expensed in the period incurred. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period.   Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets and the modified accelerated cost recovery system for federal income tax purposes. The estimated useful lives of depreciable assets are:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:85%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> Estimated Useful Lives</td> <td style="width:1%;">  </td></tr> <tr style="height:15px"> <td style="width:85%;vertical-align:bottom;"> Computer and other equipment</td> <td style="width:1%;">  </td> <td style="width:9%;"> 3 years</td> <td style="width:1%;">  </td></tr> <tr style="height:15px"> <td style="width:85%;vertical-align:bottom;"> Vehicle</td> <td style="width:1%;">  </td> <td style="width:9%;"> 5 years</td> <td style="width:1%;">  </td></tr></table>   The Company’s property and equipment consisted of the following as of February 28, 2021 and August 31, 2020:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:72%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;" colspan="2"> February 28, 2021</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;" colspan="2"> August 31, 2020</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:72%;vertical-align:top;"> Computer Equipment</td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 1,569</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 1,569</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:72%;vertical-align:top;"> Other</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 3,587</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 3,587</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:72%;vertical-align:top;"> Accumulated depreciation</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> (3,960</td> <td style="width:1%;vertical-align:bottom;"> )</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> (3,144</td> <td style="width:1%;vertical-align:bottom;"> )</td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:72%;vertical-align:top;"> Net book value</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"> 1,196</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"> 2,012</td> <td style="width:1%;">  </td></tr></table>   Depreciation expense was $387 and $653 for three months ended February 28, 2021 and February 29, 2020, respectively, and $816 and $1,307 for six months ended February 28, 2021 and February 29, 2020, respectively.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Inventories consist of raw materials and T-free distillate and are stated at the lower of cost or net realizable value using the first‑in, first‑out method. The Company periodically assesses the recoverability of its inventory and reduces the carrying value of the inventory when items are determined to be obsolete, defective or in excess of forecasted sales requirements. Inventory write‑downs for excess, defective and obsolete inventory are recorded as impairment expense in the accompanying statement of operations. The Company wrote-off $-0- and $35,118 of obsolete inventory or inventory below market value for the three months ended February 28, 2021 and February 29, 2020, respectively, and $-0- and $37,000 for the six months ended February 28, 2021 and February 29, 2020, respectively.   A summary of the Company’s inventory as of February 28, 2021 and August 31, 2020 are as follows:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:72%;vertical-align:bottom;"> Type</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;" colspan="2"> February 28, 2021</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;" colspan="2"> August 31, 2020</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:72%;vertical-align:top;"> Raw Materials</td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 450</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 450</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:72%;vertical-align:top;"> T-free Distillate</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 36,000</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 37,000</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:72%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;">  </td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:72%;vertical-align:top;"> Total Inventory</td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 36,450</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 37,450</td> <td style="width:1%;">  </td></tr></table>  </div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.   The preferred conversion and warrants would account for approximately 167,000 additional shares, the convertible debt would account for approximately 1,000,000 additional shares along with the 188,616 outstanding shares at February 28, 2021. The Company calculates diluted earnings per share by dividing the Company’s net income available to common shareholders less preferred dividends by the diluted weighted average number of shares outstanding during the period. The Company’s convertible notes and warrants are excluded from the computation of diluted earnings per share as they are anti-dilutive due to the Company’s operating losses for the six months ended February 28, 2021 and February 29, 2020.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">As discussed in Note 7 – Stockholders Equity (Deficit), during the year ended August 31, 2018, the Company issued preferred stock which accrues dividends at a rate of 5% annually. There was $99,145 and $73,995 of dividends payable at February 28, 2021 and August 31, 2020, respectively. The dividends have not been declared and are accrued in the accompanying consolidated balance sheets as a result of a contractual obligation in the Company’s preferred stock offering.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising costs totaling $156 and $466 during the three months ended February 28, 2021 and February 29, 2020, respectively, and $365 and $1,837 during the six months ended February 28, 2021 and February 29, 2020, respectively.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718. The Company issues restricted stock to employees and consultants for their services. Cost for these transactions are measured at the fair value of the equity instruments issued at the date of grant. These shares are considered fully vested and the fair market value is recognized as expense in the period granted. The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services. For agreements requiring future services, the consulting expense is to be recognized ratably over the requisite service period.   There was $-0- stock-based compensation during the three and six months ended February 28, 2021 and February 29, 2020.</div> <div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.   Pursuant to Section 850-10-20 the related parties include (a) affiliates of the Company; (b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; (d) principal owners of the Company; (e) management of the Company; (f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.   The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a) the nature of the relationship(s) involved; (b) description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, “Disclosure Update and Simplification,” amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. This analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule was effective as of November 5, 2018. The adoption of this final rule did not have a material impact on the financial statements.   In February 2018, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-02, Income Statement Reporting, Comprehensive Income (Topic 220). Effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The Company has adopted 2018-02 and determined there was no material impact on the financial statements.   In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, as part of its Simplification Initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The guidance is effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effect ASU 2019-12 will have on the consolidated financial statements and related disclosures.   In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluation the impact this ASU will have on its consolidated financial statements.   Management believes recently issued accounting pronouncements will have no impact on the financial statements of the Company.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Accounts receivable balances are established for amounts owed to the Company from its customers from the sale of products. The Company closely monitors the collectability of outstanding accounts receivable and provide an allowance for doubtful accounts based on estimated collections of outstanding amounts. The Company evaluated the accounts receivable and determined no collection loss reserve was necessary. There were $-0- outstanding accounts receivable as of February 28, 2021 and August 31, 2020.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Trademark costs are capitalized as incurred to the extent the Company expects the costs incurred to result in a trademark being awarded. The trademarks are deemed to have an indefinite life and are reviewed for impairment loss considerations annually. As of February 28, 2021 and August 31, 2020, the Company had trademarks totaling $1,680.</div> <div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">  <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:85%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> Estimated Useful Lives</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:85%;vertical-align:bottom;"> Computer and other equipment</td> <td style="width:1%;">  </td> <td style="width:9%;"> 3 years</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:85%;vertical-align:bottom;"> Vehicle</td> <td style="width:1%;">  </td> <td style="width:9%;"> 5 years</td> <td style="width:1%;">  </td></tr></table>          </div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">  <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:72%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;" colspan="2"> February 28, 2021</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;" colspan="2"> August 31, 2020</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:72%;vertical-align:top;"> Computer Equipment</td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 1,569</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 1,569</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:72%;vertical-align:top;"> Other</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 3,587</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 3,587</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:72%;vertical-align:top;"> Accumulated depreciation</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> (3,960</td> <td style="width:1%;vertical-align:bottom;"> )</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> (3,144</td> <td style="width:1%;vertical-align:bottom;"> )</td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:72%;vertical-align:top;"> Net book value</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"> 1,196</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"> 2,012</td> <td style="width:1%;">  </td></tr></table></div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">  <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:70%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:bottom;" colspan="2"> Warrants</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:11%;vertical-align:bottom;" colspan="2"> Weighted- Average Exercise Price Per Share</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:70%;vertical-align:top;"> Outstanding, August 31, 2020</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 27,532</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:2%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 50.82</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:70%;vertical-align:top;"> Granted</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:2%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:70%;vertical-align:top;"> Exercised</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:2%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:70%;vertical-align:top;"> Forfeited</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:2%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="width:70%;vertical-align:top;"> Expired</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:2%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="width:70%;vertical-align:top;"> Outstanding, February 28, 2021</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"> 27,532</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:2%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"> 50.82</td> <td style="width:1%;">  </td></tr></table></div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">  <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="2" style="width:14%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:47%;vertical-align:bottom;" colspan="10"> Outstanding</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;" colspan="6"> Exercisable</td> <td style="width:1%;">  </td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;" colspan="2"> Exercise Prices</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;" colspan="2"> Number of Warrant Shares</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;" colspan="2"> Weighted Average Exercise Price</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:bottom;" colspan="2"> Weighted Average Remaining Life (Years)</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;" colspan="2"> Number of Warrant Shares</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;" colspan="2"> Weighted Average Exercise Price</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="BORDER-BOTTOM: 1px solid;width:2%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 1px solid;width:12%;"> 50.82</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"> 27,532</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:2%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;"> 50.82</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:3%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;"> 0.66</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"> 27,532</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:2%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;"> 50.82</td> <td style="width:1%;">  </td></tr></table></div>

Gridiron has secured the rights to this proprietary formulation through its CEO, Timothy Orr (Verbal Agreement). Timothy Orr provided the formulation in connection with his receipt of 105,519 shares of common stock from the Company on October 9, 2017. 227273 0.57

3972

1105

75907

P3Y

P5Y

1569

3587

36000

37000

450

37000 0 0 35118

387

653

188616

167000

100000

572701

-2392309

6984 4921

45053

3.111

58443

3.111

0.0056

0.32

0.00001

P7Y

58443

3.4520 200000 264000 61081

200000

104032 132852

112500

0.125

-12500 0.125 Once the promissory note has been repaid, the Company shall be paid an aggregate of 3.75% of the 2020 derivative products revenues sold by the supplier

100000

167069

34088

114599

184031

140000

14000

225073

212577

If in default, the payment premium increases to 140% of the principal and interest outstanding.

0.1

The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance.

The Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.

0.35

The default interest rate for missing an installment payment shall be 18% and the conversion into common stock shall be at a price of $0.02 per common stock.

875014

825475

202500

57115

259615

555000

57115

55500

0.1

28846

The note requires nine equal payments due starting June 15, 2020 for $28,846. In the event the Company fails to make the $28,846 installment payment by the 15th day of each designated month and/or fails to cure any missed installment payment within five (5) calendars days following the due date, or the Company defaults, the defaulted amount owed shall be 130% of the total outstanding balance owed by the Company.

The note has a prepayment penalty of 115% of the principal and interest outstanding if repaid more than 30 days after note issuance. If in default, the payment premium increases to 140% of the principal and interest outstanding.

The note principal and interest are convertible into shares of common stock at the lower of $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.

2021-02-21

299590

287665

39500

2018-11-30

0.05

2018-09-15

11730

11482

10000

After February 27, 2020, the payment premium increases to 125% of the principal and interest outstanding and if in default, the payment premium increases to 140% of the principal and interest outstanding.

2020-02-27

49548

46870

. The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance

30000

0.25

3000

0.1

The Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company

61600

73469

252833 80000 0.3164 27532

27532 50.82

50.82 27532 50.82

P7M28D

27532 50.82

30000

-572701

1055317

909090

-665343

19747

0.25 The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 1 month, an exercise price of $1.66, a risk-free rate of .04% and volatility of 162%.

1454480

98879

146227

-269849

The note principal and interest are convertible into shares of common stock at $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day

50277

27000

30000

23277

3000

587772

P9M

3.04

1.28

0.0017

3.17

385272 259615 202500

57115

172608

126000

140000

46608

14000

The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.

140000

301581

146227

155909

P3Y

1.62

1.44

0.0004

2.25

383074

P1M

1.62

1.44

0.0004

2.25

19747

1.62

1.66

0.0004

2.25

P1M

98879

1.62

1.44

0.0008

2.25

P1M

2.87

1.30

0.0198

2.74

P3M

2.75

0.93

0.0161

1.54

P6M

7735

2.65

50.82

2.25

P7M28D

0.0005

1.95

50.82

7735

27.72

P3Y

0.0277

27532 P3Y

674012

555000

100000 The Company signed a Supply Agreement with Notis Global, Inc. (“NGBL”), a grower to purchase 10,000 pounds of industrial hemp (biomass) and was processed into crude during the three months ended February 29, 2020.

115000

35000 25000 25000

25000

72500

30000 units 5 dollar per unit 150000 100000 0

250000

0.2

Either party may terminate this agreement at any time upon 10 business days’ written notice.

1.30

2694514

0.05

1.30

A holder of Series B Preferred Stock will not be able to convert the shares into shares of common stock to the extent such conversion or exercise would cause the holder, together with its affiliates, to beneficially own a number of shares of common stock which would exceed 4.99% of the Company’s then outstanding shares of our common stock following such exercise or conversion, subject to a waiver by the holder upon 61 days’ prior notice to the Company.

8480000 EX-101.SCH 6 gmvp-20210228.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - NOTES RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - STOCKHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - DERIVATIVE LIABILITY link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - MATERIAL CONTRACTS link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - DERIVATIVE LIABILITY (Tables) link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - NOTES RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - NOTES PAYABLES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - STOCKHOLDERS EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - DERIVATIVE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - DERIVATIVE LIABILITY (Details 1) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - DERIVATIVE LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - MATERIAL CONTRACTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 7 gmvp-20210228_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity Interactive Data Current CONSOLIDATED BALANCE SHEETS ASSETS Current assets: Cash Inventory Prepaid expenses Notes receivable, net of discount Total current assets [Assets, Current] Other assets Equity investment, net of discount Equipment, net of accumulated depreciation of $3,960 and $3,144, respectively Trademarks Total other assets [Other Assets] Total Assets [Assets] LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses Related party payable Derivative liability Note payable, current portion Note payable, convertible net of discount Dividends payable Total current liabilities [Liabilities, Current] Commitments and contingencies Stockholders' equity (deficiency): Preferred stock, $0.001 par value; 25,000,000 shares authorized; 8,480,000 and 8,480,000 issued and outstanding as of February 28, 2021 and August 31, 2020, respectively Common stock, $0.001 par value; 200,000,000 shares authorized; 188,616 and 187,194 shares issued and outstanding as of February 28, 2021 and August 31, 2020, Respectively Additional paid in capital Accumulated deficit Total stockholders' equity (deficiency) [Stockholders' Equity Attributable to Parent] Total Liabilities and Stockholders' equity [Liabilities and Equity] Other assets Accumulated depreciation Stockholders' equity Preferred stock, shares par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Revenue Cost of Revenue Gross margin [Gross Profit] Operating expenses: Advertising Consulting fees General and administrative Professional fees Total operating expenses [Operating Expenses] Net operating income (loss) [Operating Income (Loss)] Other (income) expense: Interest expense Interest income Impairment expense Expenses related to convertible notes payable and preferred warrants: (Gain) loss on change in fair value of derivative liability Interest accretion Debt/Equity issuance costs on convertible notes payable Other (income) expense [Other Nonoperating Income] Total Other (income) expense Net income (loss) Basic and diluted income (loss) per share Weighted average number of common shares outstanding - basic CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) Statement [Table] Statement [Line Items] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-In Capital Common Stock to be Issued [Member] Accumulated Deficit Balance, shares [Shares, Issued] Balance, amount Issuance of common stock for stock subscription, shares Issuance of common stock for stock subscription, amount Repurchase and retirement of common stock, shares Repurchase and retirement of common stock, amount Dividends on preferred stock accrued Net loss, period ended February 29, 2020 Adjustment for reverse split, shares Adjustment for reverse split, amount Net loss, period ended February 28, 2021 Balance, shares Balance, amount CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) Cash flows from operating activities: Net income (loss) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Debt/stock based issue costs (Gain) Loss on change in fair value of derivative liability Interest accretion [Interest Costs Capitalized Adjustment] Amortization of convertible debt discounts Impairment expense Prior year correction to note payable, current portion (See Note 5) Realized income on investment Changes in operating assets and liabilities: Inventory [Increase (Decrease) in Inventories] Prepaid expenses [Increase (Decrease) in Prepaid Expense] Notes receivable Accounts payable and accrued expenses [Increase (Decrease) in Accounts Payable and Accrued Liabilities] Related party payable [Increase (Decrease) in Accounts Payable, Related Parties] Net cash provided by (used in) operating activities [Net Cash Provided by (Used in) Operating Activities] Cash flows from investing activities: Repurchase and retirement of common stock [Payments for Repurchase of Common Stock] Notes receivable investment [Notes receivable investment] Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] Cash flows from financing activities Proceeds from convertible notes payable Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net increase (decrease) in cash [Cash and Cash Equivalents, Period Increase (Decrease)] Cash - beginning of the year Cash - end of the year Supplemental disclosures: Interest paid Income taxes Non-cash transactions: Preferred stock dividends declared Discount on convertible note payable Issuance of common stock from shares to be issued ORGANIZATION AND DESCRIPTION OF BUSINESS NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN NOTE 3 - GOING CONCERN NOTES RECEIVABLE NOTE 4 - NOTES RECEIVABLE NOTES PAYABLE NOTE 5 - NOTES PAYABLE RELATED PARTY TRANSACTIONS NOTE 6 - RELATED PARTY TRANSACTIONS STOCKHOLDERS EQUITY NOTE 7 - STOCKHOLDERS EQUITY COMMITMENTS AND CONTINGENCIES NOTE 8 - COMMITMENTS AND CONTINGENCIES DERIVATIVE LIABILITY NOTE 9 - DERIVATIVE LIABILITY MATERIAL CONTRACTS NOTE 10 - MATERIAL CONTRACTS SUBSEQUENT EVENTS NOTE 11 - SUBSEQUENT EVENTS Basis of presentation Reclassifications Use of Estimates Cash Cash and Cash Equivalents, Policy [Policy Text Block] Revenue Recognition Fair Value of Financial Instruments Derivative Liabilities Income Taxes Principals of Consolidation Property and Equipment Inventories Basic Income (Loss) Per Share Dividends Advertising Costs Stock-Based Compensation Related Parties Recently Issued Accounting Standards Accounts Receivable Trademark EX-101.CAL 8 gmvp-20210228_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 9 gmvp-20210228_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 10 gmvp-20210228_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	6 Months Ended
Cover - shares	Feb. 28, 2021	Apr. 14, 2021
Cover [Abstract]
Entity Registrant Name	GRIDIRON BIONUTRIENTS, INC.
Entity Central Index Key	0001629205
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Feb. 28, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		188,616
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Current assets:
Cash	$ 25,294	$ 17,881
Inventory	36,450	37,450
Prepaid expenses	6,000	13,945
Notes receivable, net of discount	61,081	132,852
Total current assets	128,825	202,128
Other assets
Equity investment, net of discount	6,957	2,783
Equipment, net of accumulated depreciation of $3,960 and $3,144, respectively	1,196	2,012
Trademarks	1,680	1,680
Total other assets	9,833	6,475
Total Assets	138,658	208,603
Current liabilities:
Accounts payable and accrued expenses	522,841	443,496
Related party payable	61,600	73,469
Derivative liability	881,779	1,454,480
Note payable, current portion	10,000	10,000
Note payable, convertible net of discount	945,769	831,170
Dividends payable	99,145	73,995
Total current liabilities	2,521,134	2,886,610
Commitments and contingencies	0	0
Stockholders' equity (deficiency):
Preferred stock, $0.001 par value; 25,000,000 shares authorized; 8,480,000 and 8,480,000 issued and outstanding as of February 28, 2021 and August 31, 2020, respectively	8,480	8,480
Common stock, $0.001 par value; 200,000,000 shares authorized; 188,616 and 187,194 shares issued and outstanding as of February 28, 2021 and August 31, 2020, Respectively	188	187
Additional paid in capital	1,157,252	1,157,253
Accumulated deficit	(3,548,396)	(3,843,927)
Total stockholders' equity (deficiency)	(2,382,476)	(2,678,007)
Total Liabilities and Stockholders' equity	$ 138,658	$ 208,603

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Other assets
Accumulated depreciation	$ 3,960	$ 3,144
Stockholders' equity
Preferred stock, shares par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued	8,480,000	8,480,000
Preferred stock, shares outstanding	8,480,000	8,480,000
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	188,616	187,194
Common stock, shares outstanding	188,616	187,194

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2021	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
Revenue	$ 0	$ 0	$ 3,080	$ 633
Cost of Revenue	0	0	1,421	1,552
Gross margin	0	0	1,659	(919)
Operating expenses:
Advertising	156	466	365	1,837
Consulting fees	15,375	33,375	30,375	58,275
General and administrative	10,675	27,268	22,682	45,089
Professional fees	30,068	(13,057)	61,689	(2,848)
Total operating expenses	56,274	48,052	115,111	102,353
Net operating income (loss)	(56,274)	(48,052)	(113,452)	(103,272)
Other (income) expense:
Interest expense	40,136	40,506	76,886	43,456
Interest income	(21,018)	0	(48,743)	0
Impairment expense	0	35,118	0	37,000
Expenses related to convertible notes payable and preferred warrants:
(Gain) loss on change in fair value of derivative liability	(665,343)	909,090	(572,701)	1,055,317
Interest accretion	34,088	167,069	114,599	184,031
Debt/Equity issuance costs on convertible notes payable	0	429,800	0	476,408
Other (income) expense	(2,087)	0	(4,174)	0
Total Other (income) expense	(614,224)	1,581,583	(434,133)	1,796,212
Net income (loss)	$ 557,950	$ (1,629,635)	$ 320,681	$ (1,899,484)
Basic and diluted income (loss) per share	$ 2.97	$ (4.18)	$ 1.71	$ (4.58)
Weighted average number of common shares outstanding - basic	187,937	390,016	187,563	414,695

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital	Common Stock to be Issued [Member]	Accumulated Deficit
Balance, shares at Aug. 31, 2019		8,480,000	439,556
Balance, amount at Aug. 31, 2019	$ 32,361	$ 8,480	$ 439	$ 1,077,001	$ 160,000	$ (1,213,559)
Issuance of common stock for stock subscription, shares			742
Issuance of common stock for stock subscription, amount	0	$ 0	$ 1	159,999	(160,000)
Repurchase and retirement of common stock, shares			(253,104)
Repurchase and retirement of common stock, amount	(80,000)	$ 0	$ (253)	(79,747)	0
Dividends on preferred stock accrued	(25,150)	0	0	0	0	(25,150)
Net loss, period ended February 29, 2020	(1,899,484)	$ 0	$ 0	0	0	(1,899,484)
Balance, shares at Feb. 29, 2020		8,480,000	187,194
Balance, amount at Feb. 29, 2020	(1,972,273)	$ 8,480	$ 187	1,157,253	0	(3,138,193)
Balance, shares at Nov. 30, 2019		8,480,000	440,027
Balance, amount at Nov. 30, 2019	(250,063)	$ 8,480	$ 440	1,237,000	0	(1,495,983)
Repurchase and retirement of common stock, shares			(252,833)
Repurchase and retirement of common stock, amount	(80,000)	$ 0	$ (253)	(79,747)	0
Dividends on preferred stock accrued	(12,575)	0	0	0	0	(12,575)
Net loss, period ended February 29, 2020	(1,629,635)	$ 0	$ 0	0	0	(1,629,635)
Balance, shares at Feb. 29, 2020		8,480,000	187,194
Balance, amount at Feb. 29, 2020	(1,972,273)	$ 8,480	$ 187	1,157,253	0	(3,138,193)
Balance, shares at Aug. 31, 2020		8,480,000	187,194
Balance, amount at Aug. 31, 2020	(2,678,007)	$ 8,480	$ 187	1,157,253	0	(3,843,927)
Dividends on preferred stock accrued	(25,150)	$ 0	$ 0	0	0	(25,150)
Adjustment for reverse split, shares			1,422
Adjustment for reverse split, amount	0	$ 0	$ 1	(1)	0	0
Net loss, period ended February 28, 2021	320,681	$ 0	$ 0	0	0	320,681
Balance, shares at Feb. 28, 2021		8,480,000	188,616
Balance, amount at Feb. 28, 2021	(2,382,476)	$ 8,480	$ 188	1,157,252	0	(3,548,396)
Balance, shares at Nov. 30, 2020		8,480,000	187,194
Balance, amount at Nov. 30, 2020	(2,927,851)	$ 8,480	$ 187	1,157,253	0	(4,093,771)
Dividends on preferred stock accrued	(12,575)	$ 0	$ 0	0	0	(12,575)
Adjustment for reverse split, shares			1,422
Adjustment for reverse split, amount	0	$ 0	$ 1	(1)	0	0
Net loss, period ended February 28, 2021	557,950	$ 0	$ 0	0	0	557,950
Balance, shares at Feb. 28, 2021		8,480,000	188,616
Balance, amount at Feb. 28, 2021	$ (2,382,476)	$ 8,480	$ 188	$ 1,157,252	$ 0	$ (3,548,396)

XML 16 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) - USD ($)	6 Months Ended
	Feb. 28, 2021	Feb. 29, 2020
Cash flows from operating activities:
Net income (loss)	$ 320,681	$ (1,899,484)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	816	1,306
Debt/stock based issue costs	0	476,408
(Gain) Loss on change in fair value of derivative liability	(572,701)	1,055,317
Interest accretion	114,599	184,031
Amortization of convertible debt discounts	0	20,399
Impairment expense	0	37,000
Prior year correction to note payable, current portion (See Note 5)	0	(39,500)
Realized income on investment	(4,174)	0
Changes in operating assets and liabilities:
Inventory	1,000	(320,203)
Prepaid expenses	7,945	5,151
Notes receivable	71,771	0
Accounts payable and accrued expenses	79,345	29,872
Related party payable	(11,869)	28,514
Net cash provided by (used in) operating activities	7,413	(421,189)
Cash flows from investing activities:
Repurchase and retirement of common stock	0	(80,000)
Notes receivable investment	0	(100,000)
Net cash used in investing activities	0	(180,000)
Cash flows from financing activities
Proceeds from convertible notes payable	0	625,500
Net cash provided by financing activities	0	625,500
Net increase (decrease) in cash	7,413	24,311
Cash - beginning of the year	17,881	18,975
Cash - end of the year	25,294	43,286
Supplemental disclosures:
Interest paid	0	0
Income taxes	0	0
Non-cash transactions:
Preferred stock dividends declared	25,150	25,150
Discount on convertible note payable	0	695,000
Issuance of common stock from shares to be issued	$ 0	$ 160,000

XML 17 R7.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND DESCRIPTION OF BUSINESS	6 Months Ended
ORGANIZATION AND DESCRIPTION OF BUSINESS	Feb. 28, 2021
ORGANIZATION AND DESCRIPTION OF BUSINESS
NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS	Gridiron BioNutrients, Inc. (the “Company” or “Gridiron”) was formed under the laws of the state of Nevada on July 20, 2017 to develop and distribute a retail line of health water infused with probiotics and minerals. The Company is currently developing products which contain a proprietary blend of humic and fulvic acid, trace minerals, probiotics, electrolytes, cannabidiol (CBD) within an alkaline of pH10. Gridiron has secured the rights to this proprietary formulation through its CEO, Timothy Orr (Verbal Agreement). Timothy Orr provided the formulation in connection with his receipt of 105,519 shares of common stock from the Company on October 9, 2017. Gridiron has the exclusive right(s) to develop CBD products with this formulation. However, Gridiron is limited to developing only CBD products with this formulation and as such does not have any rights to develop products that do not contain CBD with this formulation. The Company has elected an August 31^st year end. On December 22, 2020, the Company filed Articles of Amendment to its Articles of Incorporation, as amended, which were effective on January 8, 2021 (the “Effective Date”), which effected a three hundred eight for one (308:1) reverse stock split of its outstanding common stock. Previously, on December 4, 2020 the Company filed a definitive Information Statement on Schedule 14C with the SEC notifying its stockholders that on December 2, 2020, the holders of a majority of its outstanding shares of common stock and the shares Series A Convertible Preferred Stock who were entitled to consent to the action, voting as a single class, executed a written consent in lieu of a special meeting of stockholders approving a reverse stock split of the Company’s outstanding common stock of not less than 300:1 and not more than 310:1, with the Company’s board of directors having the discretion as to when such reverse stock split would be effected (on or prior to December 2, 2021) and the exact ratio of the reverse stock split to be set at a whole number within the above range as determined by the board of directors in its sole discretion. On December 17, 2020, in accordance with such authority, the board of directors fixed the exact ratio of the reverse stock split. Acquisition and Reverse Merger On October 10, 2017, the Company completed a reverse merger with My Cloudz, Inc. (“My Cloudz”) pursuant to which the Company merged into My Cloudz on October 10, 2017. Under the terms of the merger, the Company shareholders received 227,273 common shares of My Cloudz common stock such that the Company shareholders received approximately 57% of the total common shares issued and outstanding following the merger. Due to the nominal assets and limited operations of My Cloudz prior to the merger, the transaction was accorded reverse recapitalization accounting treatment under the provision of Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 805 whereby the Company became the accounting acquirer (legal acquiree) and My Cloudz was treated as the accounting acquiree (legal acquirer). The historical financial records of the Company are those of the accounting acquirer (GridIron) adjusted to reflect the legal capital of the accounting acquiree (My Cloudz). As the transaction was treated as a recapitalization, no intangibles, including goodwill, were recognized. Concurrent with the effective date of the reverse recapitalization transaction, the Company adopted the fiscal year end of the accounting acquirer of August 31. At the date of acquisition, My Cloudz had $3,972 of cash, $1,105 of accounts payable and a related party payable of $75,907. Book values for all assets acquired and liabilities assumed equaled fair values as of the date of acquisition.

XML 18 R8.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Feb. 28, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Reclassifications

Use of Estimates

Cash

Revenue recognition

Fair Value of Financial Instruments

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.

Derivative Liabilities

Income Taxes

Principals of Consolidation

Property and Equipment

Estimated

Useful Lives

Computer and other equipment

3 years

Vehicle

5 years

The Company’s property and equipment consisted of the following as of February 28, 2021 and August 31, 2020:

	February 28, 2021			August 31, 2020
Computer Equipment	$	1,569		$	1,569
Other		3,587			3,587
Accumulated depreciation		(3,960	)		(3,144	)
Net book value	$	1,196		$	2,012

Inventories

A summary of the Company’s inventory as of February 28, 2021 and August 31, 2020 are as follows:

Type	February 28, 2021		August 31, 2020
Raw Materials	$	450	$	450
T-free Distillate		36,000		37,000

Total Inventory	$	36,450	$	37,450

Basic Income (Loss) Per Share

Dividends

Advertising Costs

Stock-Based Compensation

There was $-0- stock-based compensation during the three and six months ended February 28, 2021 and February 29, 2020.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Recently Issued Accounting Standards

Management believes recently issued accounting pronouncements will have no impact on the financial statements of the Company.

Accounts Receivable

Trademark

XML 19 R9.htm IDEA: XBRL DOCUMENT

GOING CONCERN	6 Months Ended
GOING CONCERN	Feb. 28, 2021
GOING CONCERN
NOTE 3 - GOING CONCERN	The Company’s financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company had limited revenue and net income of $320,681 for the six months ended February 28, 2021. The net income includes a non-cash $572,701 gain from change in fair value of derivative liability. The Company has working capital deficit of $2,392,309 and an accumulated deficit of $3,548,396 as of February 28, 2021. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. The ability of the Company to fully commence its operations is dependent upon, among other things, obtaining additional financing to continue operations, and execution of its business plan. In response to these concerns, management plans to fund operations through additional debt and equity financing. Debt instruments may be convertible or non-convertible and will vary based on the Company’s needs and financing options available at such times. There can be no assurance that management’s plan will be successful.

XML 20 R10.htm IDEA: XBRL DOCUMENT

NOTES RECEIVABLE	6 Months Ended
NOTES RECEIVABLE	Feb. 28, 2021
NOTES RECEIVABLE
NOTE 4 - NOTES RECEIVABLE	On January 24, 2020, the Company received a promissory note from a supplier, Notis Global, Inc. (“NGBL”). The $112,500 note was issued with an original issue discount of $12,500 or 12.5%. NGBL will repay the promissory note with 12.5% of its sales of derivative products of hemp planted and harvested in 2020. In addition, once the promissory note has been repaid, the Company shall be paid an aggregate of 3.75% of the 2020 derivative products revenues sold by the supplier. The original issue discount is amortized through the term of the note. At August 31, 2020, the Company evaluated the promissory noted under ASU 2016-16, “Financial Instruments – Credit Losses, (Topic 326)” and determined the entire balance was impaired. The Company reported an $100,000 impairment charge at August 31, 2020. On April 27, 2020, the Company entered into a Participation Agreement, effective April 27, 2020, with Libertas Funding, LLC, a Connecticut Limited Liability Company (“Libertas”), pursuant to which Libertas offered and the Company accepted to participate with Future Receivables in Purchase Agreement(s) with qualifying merchants, specifically QSI Holding Company, a Delaware Corporation (“QSI”). The Company’s participation buy-in amount was $200,000 with a participation purchase of $264,000 that is estimated to result in weekly payments to the Company for a minimum period of six months or until the full participation purchase amount has been paid. The $200,000 buy-in was recorded as a Note receivable on the accompanying consolidated balance sheets. On September 1, 2020, Libertas renegotiated this agreement and the Company will receive weekly payments for $4,921 and extended the term to 38 weeks. The previous weekly payment was $6,984. The unpaid balance was $61,081 and $132,852 at February 28, 2021 and August 31, 2020, respectively. In addition, on April 29, 2020, under the Libertas Participation Agreement, the Company received 45,053 Warrants of QSI Holding Company, a private company, (“QSI Warrants”) to purchase common stock priced at $3.111 per share for common stock par value $0.00001 expiring the 7th anniversary after the issue date. Upon issuance, the Company valued the warrants using the Black Scholes model yielding a total value of $58,443. The Company used the following assumptions upon measurement: QSI Holding Company value per common share of $3.4520, a life of 7 years, an exercise price of $3.111, a risk-free rate of 0.56% and volatility of 32%. In addition, the Company recorded a discount of $58,443 and will record income over the 7-year life of the warrants. The warrants are recorded as an equity investment in the accompanying consolidated balance sheets for $6,957 and $2,783 at February 28, 2021 and August 31, 2020, respectively. The Company recorded other income of $2,087 and $-0-, respectively for the three months ended February 28, 2021 and February 29, 2020, respectively, and $4,174 and $-0-, respectively for the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying statement of operations.

XML 21 R11.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE	6 Months Ended
NOTES PAYABLE	Feb. 28, 2021
NOTES PAYABLE
NOTE 5 - NOTES PAYABLE	Short-Term Notes Payable On September 14, 2017, the Company issued a $10,000 promissory note to a limited liability company. The loan bears interest at 5% and has a maturity date of September 15, 2018. The unpaid balance including accrued interest was $11,730 and $11,482 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note. On May 31, 2018, the Company issued a $39,500 promissory note to a company. The loan bears interest at 0% and has a maturity date of November 30, 2018. During March 2020, it was discovered the promissory note was fully paid-off on August 6, 2018 and inadvertently recorded as an operating expense for the year ended August 31, 2018. At February 29, 2020, the Company wrote-off the promissory note to operating expense. The unpaid balance was $-0- at February 28, 2021 and August 31, 2020. Convertible Notes Payable On August 27, 2019, the Company signed a convertible promissory note with an investor. The $30,000 note was issued with an original issue discount of $3,000 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 25% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on February 27, 2020. The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance. After February 27, 2020, the payment premium increases to 125% of the principal and interest outstanding and if in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. The unpaid balance including accrued interest was $49,548 and $46,870 at February 28, 2021 and August 31, 2020, respectively. On March 3, 2020, the Company was granted an extension of payment terms to August 1, 2020. The five-month extension does not modify any terms in the convertible promissory note. The Company is in default with the repayment terms of the note. On November 25, 2019, the Company signed a convertible promissory note with an investor. The $140,000 note was issued with an original issue discount of $14,000 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on May 25, 2020. The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance. If in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. On May 27, 2020, the Company was granted an extension of payment terms to November 30, 2020. The six-month extension does not modify any terms in the convertible promissory note. The unpaid balance including accrued interest was $225,073 and $212,577 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note. On January 27, 2020, the Company signed a convertible promissory note with an investor. The $555,000 note was issued with an original issue discount of $55,500 and bears interest at 10% per year. The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matured on July 27, 2020. The note has a prepayment penalty of 115% of the principal and interest outstanding if repaid more than 30 days after note issuance. If in default, the payment premium increases to 140% of the principal and interest outstanding. The original issue discount is amortized through the term of the note. The unpaid balance including accrued interest was $875,014 and $825,475 at February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note. On April 27, 2020, the Company signed a convertible promissory note with an investor. The $259,615 note was issued with an original issue discount of $57,115 and bears interest at -0-% per year. The Company recorded the self-amortizing convertible promissory note using the effective interest rate method to calculate the loan payable at $202,500 and accrued interest at $57,115. The note requires nine equal payments due starting June 15, 2020 for $28,846. In the event the Company fails to make the $28,846 installment payment by the 15^th day of each designated month and/or fails to cure any missed installment payment within five (5) calendars days following the due date, or the Company defaults, the defaulted amount owed shall be 130% of the total outstanding balance owed by the Company. The default interest rate for missing an installment payment shall be 18% and the conversion into common stock shall be at a price of $0.02 per common stock. The note principal and interest are convertible into shares of common stock at the lower of $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company. The note matures on February 21, 2021. The Company made the first payment on June 15, 2020 for $28,846 and a partial payment of $10,000 on July 15, 2020. The original issue discount is amortized through the term of the note. The unpaid principal and interest balance was $299,590 and $287,665 February 28, 2021 and August 31, 2020, respectively. The Company is in default with the repayment terms of the note. The conversion features meet the definition of a derivative liability instrument because the conversion rate is variable and therefore does not meet the “fixed-for-fixed” criteria outlined in ASC 815-40-15. As a result, the conversion features of the notes are recorded as a derivative liability at fair value and marked-to-market each period with the changes in fair value each period charged or credited to other income (expense). See Note 9 - Derivative Liability, for a further discussion. At February 28, 2021 and August 31, 2020, the outstanding principal balances of the convertible notes payable, net of debt discount was $945,769 and $831,170, respectively. The Company recorded interest accretion on the debt discount of $34,088 and $167,069 for the three months ended February 28, 2021 and February 29, 2020, respectively, and $114,599 and $184,031 for the six months ended February 28, 2021 and February 29, 2020, respectively, in the accompanying consolidated statements of operations.

XML 22 R12.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS	6 Months Ended
RELATED PARTY TRANSACTIONS	Feb. 28, 2021
RELATED PARTY TRANSACTIONS
NOTE 6 - RELATED PARTY TRANSACTIONS	As of February 28, 2021, and August 31, 2020, the Company owed $61,600 and $73,469, respectively to its President and Director. The balance due is recorded in related party payable in the accompanying consolidated balance sheets.

XML 23 R13.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS EQUITY	6 Months Ended
STOCKHOLDERS EQUITY	Feb. 28, 2021
STOCKHOLDERS EQUITY
NOTE 7 - STOCKHOLDERS EQUITY	Preferred Stock There were 8,480,000 preferred shares issued and outstanding as of February 28, 2021 and August 31, 2020. Common Stock On January 8, 2021, a 308-to-1 reverse stock split was declared effective. In accordance with the terms of all such instruments, the conversion ratio of the Company’s outstanding Series A Convertible Preferred Stock and its various convertible promissory notes, together with the exercise price of its outstanding warrants, were proportionally adjusted to give effect to the reverse stock split. The Company is authorized to issue up to 200,000,000 shares of $0.001 par value common stock. On, January 28, 2020, the Company entered into an agreement to repurchase 252,833 restricted shares of the Company’s common stock from an investor. The Company paid $80,000 or $0.3164 per share and immediately retired the shares. There were 188,616 common shares issued and outstanding as of February 28, 2021 and August 31, 2020.

XML 24 R14.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES	6 Months Ended
COMMITMENTS AND CONTINGENCIES	Feb. 28, 2021
COMMITMENTS AND CONTINGENCIES
NOTE 8 - COMMITMENTS AND CONTINGENCIES	The Company could become a party to various legal actions arising in the ordinary course of business. Matters that are probable of unfavorable outcomes to the Company and which can be reasonably estimated are accrued. Such accruals are based on information known about the matters, the Company’s estimates of the outcomes of such matters and its experience in contesting, litigating and settling similar matters. As of the date of this report, there are no pending legal proceedings to which the Company is a party or of which any of their property is the subject, nor are there any such proceedings known to be contemplated by governmental authorities.

XML 25 R15.htm IDEA: XBRL DOCUMENT

DERIVATIVE LIABILITY

6 Months Ended

Feb. 28, 2021

DERIVATIVE LIABILITY

NOTE 9 - DERIVATIVE LIABILITY

Preferred Stock Warrants

The following table summarizes all stock warrant activity for the six months ended February 28, 2021:

	Warrants		Weighted- Average Exercise Price Per Share
Outstanding, August 31, 2020		27,532	$	50.82
Granted		-		-
Exercised		-		-
Forfeited		-		-
Expired		-		-
Outstanding, February 28, 2021		27,532	$	50.82

The following table discloses information regarding outstanding and exercisable warrants at February 28, 2021:

Outstanding

Exercisable

Exercise

Prices

Number of

Warrant Shares

Weighted Average

Exercise Price

Weighted Average

Remaining Life

(Years)

Number of

Warrant Shares

Weighted Average

Exercise Price

50.82

27,532

50.82

0.66

27,532

50.82

Convertible Notes Payable

As discussed in Note 5 – Notes Payable, the Company signed various convertible promissory note with an investor as follows:

Derivative Liability Summary

XML 26 R16.htm IDEA: XBRL DOCUMENT

MATERIAL CONTRACTS	6 Months Ended
MATERIAL CONTRACTS	Feb. 28, 2021
MATERIAL CONTRACTS
NOTE 10 - MATERIAL CONTRACTS	On September 4, 2019, the Company signed an initial non-binding letter of intent with NanoPeak Performances, LLC with a subsequent addendum for the sale of the majority of its existing inventory as well as the exclusive license to Gridiron intellectual property and other intangible assets. During October 2019, NanoPeak Performances paid a $25,000 non-refundable deposit on the transaction. The Company recorded the deposit in accrued expenses in accompanying consolidated balance sheet. On February 29, 2020, the Company determined the non-binding letter of intent terminated and wrote-off the $25,000 non-refundable deposit other income. In November 2019, the Company made a strategic decision to expand into the cannabinoids (CBD) oil extraction business and on or about November 27, 2019, the Company signed a Supply Agreement with Notis Global, Inc. (“NGBL”), a grower to purchase 10,000 pounds of industrial hemp (biomass) and was processed into crude during the three months ended February 29, 2020. During November 2019, the Company paid $100,000 to the supplier and recorded the purchase in inventory in the accompanying consolidated balance sheet. During January 2020, the Company purchased an additional 30,000 pounds of industrial hemp (biomass) for $5 a pound or $150,000 under the agreement. On August 31, 2020, the Company wrote-down $115,000 of its recently purchased industrial hemp (biomass) raw material to fair market value of $35,000. On December 13, 2019, the Company signed a Toll Processing Agreement with a corporation to process industrial hemp (biomass) into the CBD product. The contract is valued at $100,000. During the year ending August 31, 2020, the Company spent $72,500 to fulfill the contract. On January 24, 2020, the Company signed a Collaboration Agreement with a supplier, Notis Global, Inc. (“NGBL”), to explore and consider potential business opportunities for the parties within various segments of the hemp CBD supply chain including cultivation, extraction and purification and retail products. As consideration for the services to be provided by the Company, NGBL shall issue to the Company 2.5 billion shares of NGBL restricted common stock. Either party may terminate this agreement at any time upon 10 business days’ written notice. The equity investment is valued at $250,000 or 20% ownership of NGBL, however, NGBL is not current with their filing with the Securities and Exchange Commission and do not have the authorized shares to fulfill the agreement. The Company evaluated the shares of NGBL and determined there was $-0- value at February 28, 2021.

XML 27 R17.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	6 Months Ended
SUBSEQUENT EVENTS	Feb. 28, 2021
SUBSEQUENT EVENTS
NOTE 11 - SUBSEQUENT EVENTS	On April 9, 2021 Company entered into an Exchange Agreement with Calvary Fund Management, LLC (“Calvary”) pursuant to which it agreed to issue Calvary 2,694,514 shares of its newly designated Series B Convertible Preferred Stock (the “Series B Preferred”) in exchange (the “Exchange”) for (i) 8,480,000 shares of its Series A Convertible Preferred Stock (the “Series A Preferred”), (ii) outstanding common stock purchase warrants (the “Warrants”), and (iii) all principal and accrued interest due under outstanding convertible promissory notes (the “Convertible Notes”, and together with the Series A Preferred and the Warrants, the “Calvary Securities”). The closing of the Exchange (the “Closing”) will occur following the satisfaction or waiver of the conditions set forth in the Exchange Agreement. On the Closing date, subject to the terms and conditions of the Exchange Agreement, the Company will issue the Series B Preferred to Calvary in exchange for the Calvary Securities (which will be cancelled and retired) in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on exemptions provided pursuant to Section 3(a)(9) of the Securities Act. The Series B Preferred Designations designated 2,694,514 shares of the Company’s blank check preferred stock as Series B Preferred Stock. In addition to rights granted to holders of Series B Preferred Stock under the Nevada Revised Statues, each holder will be entitled to the whole number of votes equal to the number of shares of common stock into which such holder’s Series B Preferred Stock would be convertible on the record date for the vote or consent of stockholders, and shall otherwise have voting rights and powers equal to the voting rights and powers of the common stock. Once issued, the shares of Series B Preferred Stock are transferrable by the holder in the holder’s sole option without the consent of the Company, subject to compliance with Section 5 of the Securities Act. The Series B Preferred Stock will rank senior to all other classes of the Company’s capital stock and has a stated value of $1.30 per share (the “Stated Value”). Subject only to the liquidation rights of the holders of Series B Preferred Stock that is then currently issued and outstanding, upon the liquidation, dissolution or winding up of the business of the Company, whether voluntary or involuntary, the Series B Preferred Stock is entitled to receive an amount per share equal to the Stated Value and then receive a pro-rata portion of the remaining assets available for distribution to the holders of common stock on an as-converted to common stock basis. From and after the Closing date, cumulative dividends on each share of Series B Preferred Stock will accrue, on a quarterly basis in arrears, at the rate of 10% per annum on the Stated Value, plus all dividends, whether declared or not, on such share of Series B Preferred Stock (the “Additional Amount”) thereon. All accrued dividends on each share of Series B Preferred Stock are to be paid upon conversion of the Series B Preferred Stock for which the applicable dividend is due. At the option of the Company dividends may be paid in cash or shares of common stock. Each holder of Series B Preferred Stock will also be entitled to receive dividends or distributions on each share of Series B Preferred Stock on an “as converted” into common stock basis when and if dividends are declared on the common stock by the Company’s Board of Directors. Dividends may be paid in cash or property, as determined by the Board of Directors. Subject to the beneficial ownership limitations described below, at any time after the Closing date, each share of Series B Preferred Stock will be convertible at the holder’s option into validly issued, fully paid and non-assessable shares of common stock at a conversion rate (the “Conversion Rate”) determined by dividing the Conversion Amount of such share of Series B Preferred Stock by the conversion price, which is (i) $1.30 or (ii) 75% of the price paid per share by investors in any subsequent offering of the Company’s common stock or common stock equivalents, subject to adjustment as provided herein, subject to adjustment as set forth below (the “Conversion Price”). The Conversion Amount is defined as the Stated Value plus the Additional Amount and any accrued and unpaid late charges with respect to such Stated Value and Additional Amount as of such date of determination. In addition, the shares of Series B Preferred Stock will be convertible at the holder’s option at the Conversion Price any time during the period commencing on the date of the occurrence of a Triggering Event (as defined in the Series B Preferred Designations). A holder of Series B Preferred Stock will not be able to convert the shares into shares of common stock to the extent such conversion or exercise would cause the holder, together with its affiliates, to beneficially own a number of shares of common stock which would exceed 4.99% of the Company’s then outstanding shares of our common stock following such exercise or conversion, subject to a waiver by the holder upon 61 days’ prior notice to the Company. The Conversion Price and the number of shares of common stock issuable upon conversion of the Series B Preferred Stock will be subject to pro-rata adjustment for stock splits, dividends and similar corporate events. In addition, if on or after April 9, 2021, the execution date of the Exchange Agreement, the Company issues or sells, or is deemed to have issued or sold, any shares of common stock, excluding certain specified excluded securities for a consideration per share (the “New Issuance Price”) less than a price equal to the Conversion Price in effect immediately prior to such issue or sale or deemed issuance or sale, then, immediately after such dilutive issuance, the Conversion Price then in effect shall be reduced to the New Issuance Price. The Series B Preferred Designations or any provision hereof (other than the beneficial ownership limitation set forth above) may be modified or amended or the provisions hereof waived with the written consent of the Company and either (i) the holders of a majority of the Series B Preferred Stock then currently outstanding, which must include Cavalry as long as Cavalry (or any of its affiliates) owns at least 5% of the Series B Preferred Stock issued pursuant to the Exchange Agreement, or (ii) Cavalry as long as Cavalry (or any of its affiliates) owns at least 5% of the Series B Preferred Stock issued pursuant to the Exchange Agreement. The Company has evaluated all other events occurring subsequently to these financial statements through April 14, 2021 and determined there were no other items to disclose.

XML 28 R18.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Feb. 28, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

Fair Value of Financial Instruments

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.

Derivative Liabilities

Income Taxes

Principals of Consolidation

Property and Equipment

		Estimated Useful Lives
Computer and other equipment		3 years
Vehicle		5 years

The Company’s property and equipment consisted of the following as of February 28, 2021 and August 31, 2020:

	February 28, 2021			August 31, 2020
Computer Equipment	$	1,569		$	1,569
Other		3,587			3,587
Accumulated depreciation		(3,960	)		(3,144	)
Net book value	$	1,196		$	2,012

Inventories

A summary of the Company’s inventory as of February 28, 2021 and August 31, 2020 are as follows:

Type	February 28, 2021		August 31, 2020
Raw Materials	$	450	$	450
T-free Distillate		36,000		37,000

Total Inventory	$	36,450	$	37,450

Basic Income (Loss) Per Share

Dividends

Advertising Costs

Stock-Based Compensation

There was $-0- stock-based compensation during the three and six months ended February 28, 2021 and February 29, 2020.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Recently Issued Accounting Standards

Management believes recently issued accounting pronouncements will have no impact on the financial statements of the Company.

Accounts Receivable

Trademark

XML 29 R19.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Feb. 28, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of Property, Plant and Equipment, estimated useful lives

		Estimated Useful Lives
Computer and other equipment		3 years
Vehicle		5 years

Schedule of Property, Plant and Equipment

	February 28, 2021			August 31, 2020
Computer Equipment	$	1,569		$	1,569
Other		3,587			3,587
Accumulated depreciation		(3,960	)		(3,144	)
Net book value	$	1,196		$	2,012

Schedule of inventories

Type	February 28, 2021		August 31, 2020
Raw Materials	$	450	$	450
T-free Distillate		36,000		37,000

Total Inventory	$	36,450	$	37,450

XML 30 R20.htm IDEA: XBRL DOCUMENT

DERIVATIVE LIABILITY (Tables)

6 Months Ended

Feb. 28, 2021

DERIVATIVE LIABILITY

Summarizes of outstanding and exercisable of stock options

	Warrants		Weighted- Average Exercise Price Per Share
Outstanding, August 31, 2020		27,532	$	50.82
Granted		-		-
Exercised		-		-
Forfeited		-		-
Expired		-		-
Outstanding, February 28, 2021		27,532	$	50.82

Summarizes of stock option activity

Outstanding

Exercisable

Exercise

Prices

Number of

Warrant Shares

Weighted Average

Exercise Price

Weighted Average

Remaining Life

(Years)

Number of

Warrant Shares

Weighted Average

Exercise Price

50.82

27,532

50.82

0.66

27,532

50.82

XML 31 R21.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) - USD ($)	6 Months Ended
	Feb. 28, 2021	Oct. 10, 2017
Secured rights to proprietary formulation agreement description	Gridiron has secured the rights to this proprietary formulation through its CEO, Timothy Orr (Verbal Agreement). Timothy Orr provided the formulation in connection with his receipt of 105,519 shares of common stock from the Company on October 9, 2017.
Business acquisition, cash balance	$ 572,701
My Cloudz [Member] \| Reverse Merger [Member]
Business acquisition, common stock, shares received		227,273
Business acquisition, common shares issued and outstanding, Percentage		57.00%
Business acquisition, cash balance		$ 3,972
Business acquisition, accounts payable		1,105
Business acquisition, related party payable		$ 75,907

XML 32 R22.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Feb. 28, 2021
Computer and other equipment [Member]
Property and equipment, estimated useful life	3 years
Vehicles [Member]
Property and equipment, estimated useful life	5 years

XML 33 R23.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Net book value	$ 1,196	$ 2,012
Accumulated depreciation	3,960	3,144
Computer Equipment [Member]
Property and equipment	1,569	1,569
Other [Member]
Property and equipment	$ 3,587	$ 3,587

XML 34 R24.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Inventory	$ 36,450	$ 37,450
T-Free Distillate [Member]
Inventory	36,000	37,000
Raw Materials [Member]
Inventory	$ 450	$ 450

XML 35 R25.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2021	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020	Aug. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash	$ 25,294	$ 43,286	$ 25,294	$ 43,286	$ 17,881	$ 18,975
Obsolete Inventory, written off	0	35,118	0	37,000
Depreciation	387	653	816	1,306
Dividends payable	99,145		99,145		73,995
Advertising costs	$ 156	466	$ 365	1,837
Common stock shares outstanding	188,616		188,616
Convertible Preferred Stock, Shares Issued upon Conversion	167,000		167,000
Additional unissued outstanding shares	100,000		100,000
Stock-based compensation	$ 0	$ 0	$ 0	$ 0
Trademarks	1,680		1,680		1,680
Accounts receivable, Outstanding	$ 0		$ 0		$ 0

XML 36 R26.htm IDEA: XBRL DOCUMENT

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended			6 Months Ended
GOING CONCERN (Details Narrative) - USD ($)	Feb. 28, 2021	Feb. 29, 2020	Nov. 30, 2019	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020
GOING CONCERN
Non cash	$ 572,701			$ 572,701
Accumulated deficit	(3,548,396)			(3,548,396)		$ (3,843,927)
Working capital deficit	(2,392,309)			(2,392,309)
Net income (loss)	$ 557,950	$ (1,629,635)	$ (269,849)	$ 320,681	$ (1,899,484)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 37 R27.htm IDEA: XBRL DOCUMENT

NOTES RECEIVABLE (Details Narrative) - USD ($)	1 Months Ended			3 Months Ended			6 Months Ended
NOTES RECEIVABLE (Details Narrative) - USD ($)	Apr. 29, 2020	Apr. 27, 2020	Jan. 24, 2020	Feb. 28, 2021	Feb. 29, 2020	Nov. 30, 2019	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020
Equity investment, net of discount				$ 6,957			$ 6,957		$ 2,783
Other (income) expenses				$ (2,087)	$ 0	$ 0	$ (4,174)	$ 0
Common stock par value				$ 0.001			$ 0.001		$ 0.001
Debt/stock based issue costs							$ 0	$ 476,408
Note receivable				$ 61,081			61,081		$ 132,852
NGBL [Member]
Notes Receivable, Principal balance			$ 112,500
Notes receivable, interest rate			12.50%
Notes receivable, discount on issue, amount			$ (12,500)
Notes receivable, discount on issue, percentage			12.50%
Notes receivable, payment, description			Once the promissory note has been repaid, the Company shall be paid an aggregate of 3.75% of the 2020 derivative products revenues sold by the supplier
Impairment charge							100,000
Libertas Participation Agreement [Member] \| QSI Holding Company [Member]
Common stock issuable upon exercise of warrants	45,053
Purchase Common Stock price per share	$ 3.111
Common stock issuable upon exercise of warrants, value	$ 58,443
Exercise price	$ 3.111
Risk-free rate	0.56%
Volatility	32.00%
Common stock par value	$ 0.00001
Warranty life in years	7 years
Debt/stock based issue costs	$ 58,443
Value per common share	$ 3.4520
Participation Agreement [Member] \| Libertas Funding, LLC [Member] \| Connecticut Limited Liability Company [Member]
Participation buy-in, amount		$ 200,000
Participation purchase, amount		$ 264,000
Unpaid balance				61,081			61,081
Note receivable				200,000			200,000
Participation purchase, unpaid balance				$ 104,032			104,032		$ 132,852
September 1, 2020 [Member]
Previous negotiated weekly payment							6,984
Renegotiated weekly payment receivables							$ 4,921

XML 38 R28.htm IDEA: XBRL DOCUMENT

NOTES PAYABLES (Details Narrative) - USD ($)		1 Months Ended						3 Months Ended		6 Months Ended
NOTES PAYABLES (Details Narrative) - USD ($)	Sep. 14, 2017	Jun. 15, 2020	Apr. 27, 2020	Jan. 20, 2020	Nov. 25, 2019	Aug. 27, 2019	May 31, 2018	Feb. 28, 2021	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020	Aug. 31, 2019
Debt instrument, interest payable								$ 34,088	$ 167,069	$ 114,599	$ 184,031
Note payable, convertible net of discount								945,769		945,769		$ 831,170
Convertible notes payable						$ 30,000
Short-Term Notes Payable 1 [Member]
Debt instrument, maturity date							Nov. 30, 2018
Promisory notes payable							$ 39,500
Notes payable, interest rate							0.00%
Short-Term Debts [Member]
Debt instrument, maturity date	Sep. 15, 2018
Promisory notes payable	$ 10,000							11,730		11,730		11,482
Notes payable, interest rate	5.00%
Convertible Promissory Notes 4 [Member]
Convertible notes payable					$ 140,000
Debt instrument, discount					$ 14,000
Unpaid accrued interest								225,073		225,073		212,577
Notes payable description					If in default, the payment premium increases to 140% of the principal and interest outstanding.
Debt instrument, interest rate, percentage					10.00%
Debt instrument, payment, description					The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance.
Debt Instrument, notice period, Description					The Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.
Debt instrument, conversion rate, percentage					35.00%
Convertible Promissory Note [Member] \| Investor [Member]
Convertible notes payable			$ 259,615	$ 555,000
Unpaid accrued interest								875,014		875,014		825,475
Debt instrument, payment, description			The note requires nine equal payments due starting June 15, 2020 for $28,846. In the event the Company fails to make the $28,846 installment payment by the 15th day of each designated month and/or fails to cure any missed installment payment within five (5) calendars days following the due date, or the Company defaults, the defaulted amount owed shall be 130% of the total outstanding balance owed by the Company.	The note has a prepayment penalty of 115% of the principal and interest outstanding if repaid more than 30 days after note issuance. If in default, the payment premium increases to 140% of the principal and interest outstanding.
Debt dafault condition, description			The default interest rate for missing an installment payment shall be 18% and the conversion into common stock shall be at a price of $0.02 per common stock.
Loan payable			$ 202,500
Accrued interest			57,115
Debt instrument, discount			$ 57,115	$ 55,500
Debt instrument, interest rate, percentage			0.00%	10.00%
Installment payment		$ 28,846
Conversion description			The note principal and interest are convertible into shares of common stock at the lower of $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.
Debt instrument, maturity date			Feb. 21, 2021
Unpaid principle balance										299,590	$ 287,665
Convertible Promissory Note 1 [Member]
Convertible notes payable						30,000
Debt instrument, discount						$ 3,000
Unpaid accrued interest								$ 49,548		$ 49,548		$ 46,870
Notes payable description						After February 27, 2020, the payment premium increases to 125% of the principal and interest outstanding and if in default, the payment premium increases to 140% of the principal and interest outstanding.
Debt instrument, interest rate, percentage						10.00%
Debt instrument, payment, description						. The note has a prepayment penalty of 110% of the principal and interest outstanding if repaid before 180 days from issuance
Debt Instrument, notice period, Description						The Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company
Debt instrument, conversion rate, percentage						25.00%
Debt instrument, discount													$ 27,000
Debt instrument, maturity date						Feb. 27, 2020

XML 39 R29.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Due to related party	$ 61,600	$ 73,469
President And Director [Member]
Due to related party	$ 61,600	$ 73,469

XML 40 R30.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS EQUITY (Details Narrative) - USD ($)	1 Months Ended
STOCKHOLDERS EQUITY (Details Narrative) - USD ($)	Jan. 28, 2020	Feb. 28, 2021	Aug. 31, 2020
STOCKHOLDERS EQUITY
Common stock, par value		$ 0.001	$ 0.001
Common stock, shares authorized		200,000,000	200,000,000
Common stock, shares issued		188,616	187,194
Common stock, shares outstanding		188,616	187,194
Preferred stock, shares issued		8,480,000	8,480,000
Preferred stock, shares outstanding		8,480,000	8,480,000
Restricted shares of common stock	252,833
Common stock shares, issuable value	$ 80,000
Common stock shares, issuable par value	$ 0.3164

XML 41 R31.htm IDEA: XBRL DOCUMENT

DERIVATIVE LIABILITY (Details) - Warrants [Member]	6 Months Ended
DERIVATIVE LIABILITY (Details) - Warrants [Member]	Feb. 28, 2021 $ / shares shares
Number of warrants/rights, Outstanding, August 31, 2020 \| shares	27,532
Number of warrants/rights, Granted \| shares	0
Number of warrants/rights, Exercised \| shares	0
Number of warrants/rights, Forfeited \| shares	0
Number of warrants/rights, Expired \| shares	0
Number of warrants/rights, Outstanding, November 30, 2020 \| shares	27,532
Weighted Average Exercise Price Per Share, Outstanding, August 31, 2020 \| $ / shares	$ 50.82
Weighted Average Exercise Price Per Share, Granted \| $ / shares	0
Weighted Average Exercise Price Per Share, Exercised \| $ / shares	0
Weighted Average Exercise Price Per Share, Forfeited \| $ / shares	0
Weighted Average Exercise Price Per Share, Expired \| $ / shares	0
Weighted Average Exercise Price Per Share, Outstanding, November 30, 2020 \| $ / shares	$ 50.82

XML 42 R32.htm IDEA: XBRL DOCUMENT

DERIVATIVE LIABILITY (Details 1) - Stock options [Member]	6 Months Ended
	Feb. 28, 2021 $ / shares shares
Number of Warrants Shares, Outstanding \| shares	27,532
Weighted Average Exercise Price, Outstanding \| $ / shares	$ 50.82
Weighted average remaining contractual life (Years), Outstanding	7 months 28 days
Number of Outstanding, Exercisable \| shares	27,532
Weighted Average Exercise Price, Exercisable \| $ / shares	$ 50.82

XML 43 R33.htm IDEA: XBRL DOCUMENT

DERIVATIVE LIABILITY (Details Narrative) - USD ($)	1 Months Ended				3 Months Ended			6 Months Ended		12 Months Ended
DERIVATIVE LIABILITY (Details Narrative) - USD ($)	Apr. 27, 2020	Jan. 27, 2020	Nov. 25, 2019	Aug. 27, 2019	Feb. 28, 2021	Feb. 29, 2020	Nov. 30, 2019	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2019	Aug. 31, 2020	Jan. 20, 2020
Interest accretion					$ 34,088	$ 167,069		$ 114,599	$ 184,031
Convertible notes payable				$ 30,000
Change in fair value of derivative liabilities					(665,343)	909,090		(572,701)	1,055,317
Recorded expense					19,747
Discount on conversion into common stock				25.00%
Derivative liability					881,779			$ 881,779		$ 1,454,480	$ 1,454,480
Derivative liability description								The Company used the following assumptions upon measurement: value per common share of $2.25, a remaining life of 1 month, an exercise price of $1.66, a risk-free rate of .04% and volatility of 162%.
(Gain) loss on change in fair value of derivative liability							$ 146,227	$ 98,879
Net income (loss)					$ 557,950	$ (1,629,635)	(269,849)	320,681	(1,899,484)
Debt/stock based issue costs								0	$ 476,408
Derivative Liability Summary [Member]
Change in fair value of derivative liabilities							$ 146,227	$ 301,581
Derivatives liability [Member]
Expected volatility rate								265.00%
Exercise price					$ 50.82			$ 50.82
Value per common share					2.25			$ 2.25
Expected term (in years)								7 months 28 days
Recorded income from derivative liability								$ 7,735
Risk-free interest rate								0.05%
Derivatives [Member] \| August 31, 2018 [Member]
Expected volatility rate								195.00%
Exercise price					50.82			$ 50.82
Value per common share					$ 27.72			$ 27.72
Expected term (in years)								3 years
Risk-free interest rate								2.77%
Change in fair value of derivative liabilities					$ 7,735			$ 7,735
Detachable warrants					27,532			27,532
Exercisable period								3 years
Debt/stock based issue costs								$ 674,012
Monte Carlo Simulation Model [Member]
Derivative liability					$ 587,772			587,772
Debt instrument, discount					$ 57,115			$ 57,115
Life of debt instrument								9 months
Expected volatility rate								304.00%
Exercise price					$ 1.28			$ 1.28
Risk-free interest rate								0.17%
Value per common share					$ 3.17			$ 3.17
Loss on issuance of debt					$ 385,272			$ 385,272
Total Discount on debt					259,615			259,615
Derivative discount					$ 202,500			202,500
Revaluation of Derivative Liability [Member]
Change in fair value of derivative liabilities								$ 383,074
Life of debt instrument								1 month
Expected volatility rate								162.00%
Exercise price					$ 1.44			$ 1.44
Risk-free interest rate								0.04%
Value per common share					$ 2.25			$ 2.25
Investor [Member]
Conversion description		The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.
Convertible promissory note		$ 555,000
Convertible Promissory Note [Member] \| Investor [Member]
Convertible notes payable	$ 259,615											$ 555,000
Conversion description	The note principal and interest are convertible into shares of common stock at $0.02 per share or a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day
Derivative discount	$ 57,115											$ 55,500
Convertible Promissory Note 1 [Member]
Convertible notes payable				$ 30,000
Derivative liability					$ 50,277			$ 50,277
Net income (loss)										23,277
Derivative discount										27,000
Debt instrument, discount				$ 3,000
Debt instrument, conversion rate, percentage				25.00%
Derivative aggregated discount										30,000
Original issue discount										$ 3,000
Convertible Promissory Note 1 [Member] \| Derivative liabilities [Member]
Expected volatility rate										287.00%
Exercise price										$ 1.30
Risk-free interest rate										1.98%
Value per common share										$ 2.74
Expected term (in years)								3 months
Convertible Promissory Note 2 [Member]
Derivative liability					172,608			$ 172,608
Net income (loss)								46,608
Derivative discount					126,000			126,000
Derivative aggregated discount					$ 140,000			140,000
Original issue discount								14,000
Terms of conversion feature			The note principal and interest are convertible into shares of common stock at a 35% discount to the lowest traded price of the Company’s common stock during the 10 prior trading days including the day the notice of conversion is received by the Company.
Convertible promissory note payabe			$ 140,000
Convertible Promissory Note 2 [Member] \| Derivatives Liabilities Revaluation [Member]
Change in fair value of derivative liabilities								$ 98,879
Expected volatility rate								162.00%
Exercise price					$ 1.44			$ 1.44
Risk-free interest rate								0.08%
Value per common share					2.25			$ 2.25
Expected term (in years)								1 month
Convertible Promissory Note 2 [Member] \| Derivative liabilities [Member]
Expected volatility rate								275.00%
Exercise price					0.93			$ 0.93
Risk-free interest rate								1.61%
Value per common share					1.54			$ 1.54
Expected term (in years)								6 months
Convertible Notes Payable [Member] \| Derivative Liability [Member]
Change in fair value of derivative liabilities								$ 155,909
Life of debt instrument								3 years
Expected volatility rate								162.00%
Exercise price					1.44			$ 1.44
Risk-free interest rate								0.04%
Value per common share					2.25			$ 2.25
Convertible Notes Note 1 [Member] \| Derivatives liability revaluation [Member]
Change in fair value of derivative liabilities								$ 19,747
Expected volatility rate								162.00%
Exercise price					1.66			$ 1.66
Risk-free interest rate								0.04%
Value per common share					$ 2.25			$ 2.25
Expected term (in years)								1 month

XML 44 R34.htm IDEA: XBRL DOCUMENT

MATERIAL CONTRACTS (Details Narrative) - USD ($)	1 Months Ended						12 Months Ended
MATERIAL CONTRACTS (Details Narrative) - USD ($)	Feb. 29, 2020	Jan. 31, 2020	Jan. 24, 2020	Dec. 13, 2019	Nov. 27, 2019	Oct. 31, 2019	Aug. 31, 2020	Feb. 28, 2021
Equity investment method							$ 2,783	$ 6,957
Toll Processing Agreement [Member]
Contract price				$ 100,000
NGBL [Member] \| Collaboration Agreement [Member]
Fair value of NGBL shares								$ 0
Sale of Stock, Number of Shares Issued in Transaction			250,000
Equity investment method			$ 250,000
Ownership percentage			20.00%
Description of agreement termination period			Either party may terminate this agreement at any time upon 10 business days’ written notice.
Non-binding letter of intent [Member] \| NanoPeak Performances, LLC [Member]
Non-rerfundable deposits received	$ 25,000					$ 25,000
Non-rerfundable deposits received, written off							25,000
Contract fullfillment expenses							72,500
Purchase of industrial hemp (biomass)		30000 units
Industrial hemp (biomass), price per unit		5 dollar per unit
Industrial hemp (biomass), Total amount		$ 150,000
Industrial Hemp (biomass) [Member]
Contract price					$ 100,000
Supply agreement with grower to purchase description					The Company signed a Supply Agreement with Notis Global, Inc. (“NGBL”), a grower to purchase 10,000 pounds of industrial hemp (biomass) and was processed into crude during the three months ended February 29, 2020.
Obsolete Inventory, written off							115,000
Fair market value							$ 35,000

XML 45 R35.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS (Details Narrative) - $ / shares	Apr. 09, 2021	Feb. 28, 2021	Aug. 31, 2020
Common stock, par value		$ 0.001	$ 0.001
Subsequent Event [Member] \| Calavary Fund Management LLC [Member] \| Exchange Agreement [Member] \| Series B Convertible Preferred Stock [Member]
Common stock, par value	$ 1.30
Preferred stock, shares designated	2,694,514
Ownership percentage	5.00%
Conversion price	$ 1.30
Conversion description	A holder of Series B Preferred Stock will not be able to convert the shares into shares of common stock to the extent such conversion or exercise would cause the holder, together with its affiliates, to beneficially own a number of shares of common stock which would exceed 4.99% of the Company’s then outstanding shares of our common stock following such exercise or conversion, subject to a waiver by the holder upon 61 days’ prior notice to the Company.
Preferred stock, shares issued in exchange with shares designated	8,480,000

EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 47 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 153 336 1 false 51 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://gridiron.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://gridiron.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://gridiron.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://gridiron.com/role/ConsolidatedStatementsOfOperationsUnaudited CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://gridiron.com/role/ConsolidatedStatementOfStockholdersEquityDeficit CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) Sheet http://gridiron.com/role/ConsolidatedStatementsOfCashFlowUnaudited CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) Statements 6 false false R7.htm 000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://gridiron.com/role/OrganizationAndDescriptionOfBusiness ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://gridiron.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 000009 - Disclosure - GOING CONCERN Sheet http://gridiron.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 000010 - Disclosure - NOTES RECEIVABLE Notes http://gridiron.com/role/NotesReceivable NOTES RECEIVABLE Notes 10 false false R11.htm 000011 - Disclosure - NOTES PAYABLE Notes http://gridiron.com/role/NotesPayable NOTES PAYABLE Notes 11 false false R12.htm 000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://gridiron.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 000013 - Disclosure - STOCKHOLDERS EQUITY Sheet http://gridiron.com/role/StockholdersEquity STOCKHOLDERS EQUITY Notes 13 false false R14.htm 000014 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://gridiron.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 14 false false R15.htm 000015 - Disclosure - DERIVATIVE LIABILITY Sheet http://gridiron.com/role/DerivativeLiability DERIVATIVE LIABILITY Notes 15 false false R16.htm 000016 - Disclosure - MATERIAL CONTRACTS Sheet http://gridiron.com/role/MaterialContracts MATERIAL CONTRACTS Notes 16 false false R17.htm 000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://gridiron.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://gridiron.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 000020 - Disclosure - DERIVATIVE LIABILITY (Tables) Sheet http://gridiron.com/role/DerivativeLiabilityTables DERIVATIVE LIABILITY (Tables) Tables http://gridiron.com/role/DerivativeLiability 20 false false R21.htm 000021 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) Sheet http://gridiron.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) Details http://gridiron.com/role/OrganizationAndDescriptionOfBusiness 21 false false R22.htm 000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesDetails1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Details http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) Sheet http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesDetails2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) Details http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://gridiron.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 000026 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://gridiron.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://gridiron.com/role/GoingConcern 26 false false R27.htm 000027 - Disclosure - NOTES RECEIVABLE (Details Narrative) Notes http://gridiron.com/role/NotesReceivableDetailsNarrative NOTES RECEIVABLE (Details Narrative) Details http://gridiron.com/role/NotesReceivable 27 false false R28.htm 000028 - Disclosure - NOTES PAYABLES (Details Narrative) Notes http://gridiron.com/role/NotesPayablesDetailsNarrative NOTES PAYABLES (Details Narrative) Details http://gridiron.com/role/NotesPayable 28 false false R29.htm 000029 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://gridiron.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://gridiron.com/role/RelatedPartyTransactions 29 false false R30.htm 000030 - Disclosure - STOCKHOLDERS EQUITY (Details Narrative) Sheet http://gridiron.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS EQUITY (Details Narrative) Details http://gridiron.com/role/StockholdersEquity 30 false false R31.htm 000031 - Disclosure - DERIVATIVE LIABILITY (Details) Sheet http://gridiron.com/role/DerivativeLiabilityDetails DERIVATIVE LIABILITY (Details) Details http://gridiron.com/role/DerivativeLiabilityTables 31 false false R32.htm 000032 - Disclosure - DERIVATIVE LIABILITY (Details 1) Sheet http://gridiron.com/role/DerivativeLiabilityDetails1 DERIVATIVE LIABILITY (Details 1) Details http://gridiron.com/role/DerivativeLiabilityTables 32 false false R33.htm 000033 - Disclosure - DERIVATIVE LIABILITY (Details Narrative) Sheet http://gridiron.com/role/DerivativeLiabilityDetailsNarrative DERIVATIVE LIABILITY (Details Narrative) Details http://gridiron.com/role/DerivativeLiabilityTables 33 false false R34.htm 000034 - Disclosure - MATERIAL CONTRACTS (Details Narrative) Sheet http://gridiron.com/role/MaterialContractsDetailsNarrative MATERIAL CONTRACTS (Details Narrative) Details http://gridiron.com/role/MaterialContracts 34 false false R35.htm 000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://gridiron.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://gridiron.com/role/SubsequentEvents 35 false false All Reports Book All Reports gmvp-20210228.xml gmvp-20210228.xsd gmvp-20210228_cal.xml gmvp-20210228_def.xml gmvp-20210228_lab.xml gmvp-20210228_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 true true ZIP 51 0001477932-21-002300-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-21-002300-xbrl.zip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end

DERIVATIVE LIABILITY (Details) - Warrants [Member]	6 Months Ended
DERIVATIVE LIABILITY (Details) - Warrants [Member]	Feb. 28, 2021 $ / shares shares
Number of warrants/rights, Outstanding, August 31, 2020 \| shares	27,532
Number of warrants/rights, Granted \| shares	0
Number of warrants/rights, Exercised \| shares	0
Number of warrants/rights, Forfeited \| shares	0
Number of warrants/rights, Expired \| shares	0
Number of warrants/rights, Outstanding, November 30, 2020 \| shares	27,532
Weighted Average Exercise Price Per Share, Outstanding, August 31, 2020 \| $ / shares	$ 50.82
Weighted Average Exercise Price Per Share, Granted \| $ / shares	0
Weighted Average Exercise Price Per Share, Exercised \| $ / shares	0
Weighted Average Exercise Price Per Share, Forfeited \| $ / shares	0
Weighted Average Exercise Price Per Share, Expired \| $ / shares	0
Weighted Average Exercise Price Per Share, Outstanding, November 30, 2020 \| $ / shares	$ 50.82